1 | equal | 5,791 |
2 | =1 | 196 |
3 | =2 | 190 |
4 | =3 | 185 |
5 | =10 | 158 |
6 | =30 | 138 |
7 | =40 | 135 |
8 | =65 | 128 |
9 | =5 | 122 |
10 | =60 | 115 |
11 | =7 | 98 |
12 | =4 | 96 |
13 | =70 | 94 |
14 | =18 | 88 |
15 | =20 | 88 |
16 | =6 | 83 |
17 | =25 | 69 |
18 | =35 | 69 |
19 | =12 | 64 |
20 | =15 | 64 |
21 | =45 | 63 |
22 | =80 | 60 |
23 | =100 | 58 |
24 | =8 | 55 |
25 | =90 | 55 |
26 | =140 | 51 |
27 | =75 | 45 |
28 | =16 | 36 |
29 | =55 | 34 |
30 | =160 | 29 |
31 | =200 | 29 |
32 | =130 | 28 |
33 | =85 | 27 |
34 | =1.5 | 25 |
35 | =9 | 24 |
36 | =0.40 | 23 |
37 | =150 | 23 |
38 | =14 | 22 |
39 | =0.1 | 21 |
40 | =0.5 | 21 |
41 | =2.0 | 21 |
42 | =13 | 20 |
43 | =21 | 20 |
44 | =24 | 20 |
45 | =120 | 19 |
46 | =2.5 | 18 |
47 | =48 | 18 |
48 | =72 | 18 |
49 | =11 | 17 |
50 | =110 | 16 |
51 | =33 | 16 |
52 | ≥27 | 16 |
53 | =26 | 15 |
54 | =3.0 | 15 |
55 | =32 | 15 |
56 | =37 | 15 |
57 | =500 | 15 |
58 | =0.2 | 14 |
59 | =1.0 | 14 |
60 | =17 | 14 |
61 | =36 | 14 |
62 | =1.2 | 13 |
63 | =140/90 | 13 |
64 | =28 | 13 |
65 | =38 | 13 |
66 | =0.9 | 12 |
67 | =29 | 12 |
68 | =300 | 12 |
69 | =400 | 12 |
70 | =6.5 | 12 |
71 | =19 | 11 |
72 | =22 | 11 |
73 | =3.5 | 11 |
74 | =34 | 11 |
75 | =4.0 | 11 |
76 | =67 | 11 |
77 | =23 | 10 |
78 | =250 | 10 |
79 | =4.5 | 10 |
80 | =47 | 10 |
81 | =5.5 | 10 |
82 | =69 | 10 |
83 | =95 | 10 |
84 | =0.3 | 9 |
85 | =27 | 9 |
86 | =41 | 9 |
87 | =5.6 | 9 |
88 | =52 | 9 |
89 | =1.3 | 8 |
90 | =1.4 | 8 |
91 | =105 | 8 |
92 | =180 | 8 |
93 | =2.2 | 8 |
94 | =240 | 8 |
95 | =39 | 8 |
96 | =64 | 8 |
97 | =cin3 | 8 |
98 | =-2.5 | 7 |
99 | =1.40 | 7 |
100 | =190 | 7 |
101 | =31 | 7 |
102 | =350 | 7 |
103 | =56 | 7 |
104 | =7.5 | 7 |
105 | =7.8 | 7 |
106 | sf2/asf | 7 |
107 | =1.1 | 6 |
108 | =100,000 | 6 |
109 | =44 | 6 |
110 | =5.2 | 6 |
111 | =57 | 6 |
112 | =6.0 | 6 |
113 | =6.2 | 6 |
114 | =7.0 | 6 |
115 | =76 | 6 |
116 | =800 | 6 |
117 | =96 | 6 |
118 | =ii | 6 |
119 | ssz+hcq | 6 |
120 | =1.7 | 5 |
121 | =1.8 | 5 |
122 | =10,000 | 5 |
123 | =12.5 | 5 |
124 | =126 | 5 |
125 | =135 | 5 |
126 | =145 | 5 |
127 | =2.6 | 5 |
128 | =220 | 5 |
129 | =3.2 | 5 |
130 | =51 | 5 |
131 | =73 | 5 |
132 | =78 | 5 |
133 | =84 | 5 |
134 | =cin2 | 5 |
135 | oxyethylene | 5 |
136 | -dhpg | 4 |
137 | 8-5 | 4 |
138 | =1.9 | 4 |
139 | =11.1 | 4 |
140 | =125 | 4 |
141 | =160/90 | 4 |
142 | =163 | 4 |
143 | =175 | 4 |
144 | =2+ | 4 |
145 | =2.7 | 4 |
146 | =20/40 | 4 |
147 | =5000 | 4 |
148 | =54 | 4 |
149 | =59 | 4 |
150 | =74 | 4 |
151 | =82 | 4 |
152 | =89 | 4 |
153 | =91 | 4 |
154 | =97 | 4 |
155 | =98 | 4 |
156 | admission* | 4 |
157 | antimicrob* | 4 |
158 | proced* | 4 |
159 | tech* | 4 |
160 | yào | 4 |
161 | ≥2.7 | 4 |
162 | 10 | 4 |
163 | 'days | 3 |
164 | 148-μg | 3 |
165 | =-3 | 3 |
166 | =0.4 | 3 |
167 | =10.5 | 3 |
168 | =115 | 3 |
169 | =117 | 3 |
170 | =119 | 3 |
171 | =132 | 3 |
172 | =144 | 3 |
173 | =160/100 | 3 |
174 | =2.60 | 3 |
175 | =25.2 | 3 |
176 | =3.4 | 3 |
177 | =42 | 3 |
178 | =43 | 3 |
179 | =600 | 3 |
180 | =700 | 3 |
181 | =71 | 3 |
182 | =75th | 3 |
183 | =87 | 3 |
184 | =88 | 3 |
185 | =9.0 | 3 |
186 | =iii | 3 |
187 | aminophylline-treated | 3 |
188 | gel/cream | 3 |
189 | head-braces | 3 |
190 | hospitali* | 3 |
191 | inpatient* | 3 |
192 | lactadherin | 3 |
193 | lighters | 3 |
194 | mivazerol | 3 |
195 | self-manag* | 3 |
196 | spermatocele | 3 |
197 | ≤2.6 | 3 |
198 | 'preferences | 2 |
199 | -18:3n-3 | 2 |
200 | -23.11 | 2 |
201 | -230 | 2 |
202 | -551a | 2 |
203 | -9.76 | 2 |
204 | -sma | 2 |
205 | /13.8 | 2 |
206 | 0.35-0.40 | 2 |
207 | 10-11.1 | 2 |
208 | 138±35 | 2 |
209 | 151-159/100-109 | 2 |
210 | 25·5 | 2 |
211 | 25×2×2 | 2 |
212 | 3.2-3.8 | 2 |
213 | 30.62 | 2 |
214 | 34.74 | 2 |
215 | 3x/wk | 2 |
216 | 4776 | 2 |
217 | 5·11 | 2 |
218 | 65·8 | 2 |
219 | 69.05 | 2 |
220 | 7+/-18 | 2 |
221 | 71.04 | 2 |
222 | 75+/-8 | 2 |
223 | 77.07 | 2 |
224 | 8·16 | 2 |
225 | 8×9 | 2 |
226 | =-1.0 | 2 |
227 | =-9 | 2 |
228 | =1.20 | 2 |
229 | =1.50 | 2 |
230 | =1/3 | 2 |
231 | =10-20 | 2 |
232 | =100.1 | 2 |
233 | =101 | 2 |
234 | =107 | 2 |
235 | =109 | 2 |
236 | =11.3 | 2 |
237 | =111 | 2 |
238 | =12.0 | 2 |
239 | =123 | 2 |
240 | =130/80 | 2 |
241 | =133 | 2 |
242 | =134 | 2 |
243 | =140/100 | 2 |
244 | =15,000 | 2 |
245 | =15/h | 2 |
246 | =155 | 2 |
247 | =17.5 | 2 |
248 | =170 | 2 |
249 | =18.2 | 2 |
250 | =183 | 2 |
251 | =19.4 | 2 |
252 | =2-min | 2 |
253 | =2.67 | 2 |
254 | =20/200 | 2 |
255 | =24.9 | 2 |
256 | =26.5 | 2 |
257 | =27.5 | 2 |
258 | =3,000 | 2 |
259 | =3.09 | 2 |
260 | =3.3 | 2 |
261 | =3.36 | 2 |
262 | =3.88 | 2 |
263 | =36.1 | 2 |
264 | =4.14 | 2 |
265 | =4.17 | 2 |
266 | =4.20 | 2 |
267 | =5,759 | 2 |
268 | =5.17 | 2 |
269 | =5/10 | 2 |
270 | =500/microl | 2 |
271 | =62.5 | 2 |
272 | =65.0 | 2 |
273 | =7.4 | 2 |
274 | =8.0 | 2 |
275 | =8.7 | 2 |
276 | =81 | 2 |
277 | =94 | 2 |
278 | =ff=cap | 2 |
279 | adhere* | 2 |
280 | agotf | 2 |
281 | amnestic-mci | 2 |
282 | anh/ibr/pbr | 2 |
283 | arg130 | 2 |
284 | asusto | 2 |
285 | beta-hydroxylovastatin | 2 |
286 | bradyphrenia | 2 |
287 | brush/spatula | 2 |
288 | butyroyl-arginine | 2 |
289 | cd4-cd8+ | 2 |
290 | clec4d | 2 |
291 | co-produced | 2 |
292 | convent* | 2 |
293 | corticosteroid* | 2 |
294 | danc* | 2 |
295 | delphis | 2 |
296 | demand/semi | 2 |
297 | drink* | 2 |
298 | dropout* | 2 |
299 | dual-treatment | 2 |
300 | dysport™ | 2 |
301 | elixophyllin | 2 |
302 | endomyoparametritis | 2 |
303 | ethibond™ | 2 |
304 | gym* | 2 |
305 | high-treatment | 2 |
306 | icn160 | 2 |
307 | ipsv/cedv | 2 |
308 | isodicentric | 2 |
309 | ll5β | 2 |
310 | lvef≥45 | 2 |
311 | mic≥0.25 | 2 |
312 | months-12.8 | 2 |
313 | moxibution | 2 |
314 | non-professional* | 2 |
315 | p97 | 2 |
316 | perpendic-ular | 2 |
317 | placebo.treatment | 2 |
318 | rhabdmyolysis | 2 |
319 | s-trans-ch2chċo | 2 |
320 | sf-il-1β | 2 |
321 | spp100 | 2 |
322 | sβ0thal | 2 |
323 | tbc-exposed | 2 |
324 | tnf-blocker-resistant | 2 |
325 | top-rope | 2 |
326 | trihydroxylation | 2 |
327 | |q| | 2 |
328 | ~1.9 | 2 |
329 | ∼1100 | 2 |
330 | ≤125/75 | 2 |
331 | ≤46 | 2 |
332 | ≥110/70 | 2 |
333 | ≥140/85 | 2 |
334 | ⩾80 | 2 |
335 | 'divya | 1 |
336 | 'headgear | 1 |
337 | 'musa-pelo | 1 |
338 | 'teflon'® | 1 |
339 | 'wheeze | 1 |
340 | +0.0678 | 1 |
341 | +1·1 | 1 |
342 | +rt=66 | 1 |
343 | ,165 | 1 |
344 | -.99 | 1 |
345 | -0.2±57 | 1 |
346 | -0.7±2.1/-1.6±1.2 | 1 |
347 | -1,186 | 1 |
348 | -10.3/-6.9 | 1 |
349 | -10.9±20.1 | 1 |
350 | -11.1±10.1 | 1 |
351 | -11.3±12.2 | 1 |
352 | -13.03 | 1 |
353 | -138.2 | 1 |
354 | -14.1/-8.7 | 1 |
355 | -14.2±20.1 | 1 |
356 | -16±1.7 | 1 |
357 | -16±8.7 | 1 |
358 | -18-antibody- | 1 |
359 | -18.1±12.2 | 1 |
360 | -2-butoxymethyl | 1 |
361 | -2.1/-1.5 | 1 |
362 | -2.9±0.9 | 1 |
363 | -20.3±19.2 | 1 |
364 | -21.06 | 1 |
365 | -23.14 | 1 |
366 | -299.8 | 1 |
367 | -30.1/-19.0 | 1 |
368 | -31.38 | 1 |
369 | -32.4±8.3 | 1 |
370 | -32mg/day | 1 |
371 | -363mg/day | 1 |
372 | -38.4±2.8 | 1 |
373 | -4,072 | 1 |
374 | -8.4±8.7 | 1 |
375 | -90±154 | 1 |
376 | -arylalkyl | 1 |
377 | -doxepin | 1 |
378 | -fluoride-pet/ct | 1 |
379 | -imidapril | 1 |
380 | -insufflation | 1 |
381 | /+0.4 | 1 |
382 | /-1.9 | 1 |
383 | /0.35 | 1 |
384 | /5.7 | 1 |
385 | /f/kg=4.441 | 1 |
386 | /vf | 1 |
387 | 0.010-0.100 | 1 |
388 | 0.02-1.0 | 1 |
389 | 0.04-2.560 | 1 |
390 | 0.12,95 | 1 |
391 | 0.14-0.15 | 1 |
392 | 0.16-150 | 1 |
393 | 0.20-2.00 | 1 |
394 | 0.25mg/ | 1 |
395 | 0.28-0.50 | 1 |
396 | 0.32±0.027 | 1 |
397 | 0.33:95 | 1 |
398 | 0.39mmol/l | 1 |
399 | 0.5+ | 1 |
400 | 0.5-300 | 1 |
401 | 0.88,95 | 1 |
402 | 0.96-1.86 | 1 |
403 | 0·992 | 1 |
404 | 1,03 | 1 |
405 | 1,1,1-trichloropropene | 1 |
406 | 1,400-mg | 1 |
407 | 1,575°c | 1 |
408 | 1.0320 | 1 |
409 | 1.04,95 | 1 |
410 | 1.57-2.38 | 1 |
411 | 1.57±0.96 | 1 |
412 | 1.6±8.6 | 1 |
413 | 1.779 | 1 |
414 | 1.88/0.86 | 1 |
415 | 1.95-21.2 | 1 |
416 | 1.968 | 1 |
417 | 1/133 | 1 |
418 | 1/clearance | 1 |
419 | 10-13.4 | 1 |
420 | 10.46+/-1.24 | 1 |
421 | 10.46±3.8 | 1 |
422 | 105/80 | 1 |
423 | 106/5.9-48.7 | 1 |
424 | 107/52 | 1 |
425 | 108+/-37 | 1 |
426 | 109+/-11 | 1 |
427 | 10x10x3 | 1 |
428 | 11.0/8.1 | 1 |
429 | 11.108 | 1 |
430 | 11.2/8.5 | 1 |
431 | 11.20-55.60 | 1 |
432 | 115.14 | 1 |
433 | 12.9/7.7 | 1 |
434 | 12/diet | 1 |
435 | 120.99 | 1 |
436 | 120mg/d | 1 |
437 | 121-139/81-89 | 1 |
438 | 128±86 | 1 |
439 | 13.2/8.5 | 1 |
440 | 13.3/7.8 | 1 |
441 | 13.4±2.4 | 1 |
442 | 13.711 | 1 |
443 | 13.8-80.3 | 1 |
444 | 13.92±2.75 | 1 |
445 | 130-140/70-80 | 1 |
446 | 130/77 | 1 |
447 | 131/78 | 1 |
448 | 132.3/74.0 | 1 |
449 | 135-159 | 1 |
450 | 138.62 | 1 |
451 | 138.896 | 1 |
452 | 138±12 | 1 |
453 | 14.90±7.28 | 1 |
454 | 142-210 | 1 |
455 | 142/81 | 1 |
456 | 15-19.9 | 1 |
457 | 150.6/99.1 | 1 |
458 | 154±11 | 1 |
459 | 156.93 | 1 |
460 | 16.2-58.0 | 1 |
461 | 16.470 | 1 |
462 | 16.627 | 1 |
463 | 160-170 | 1 |
464 | 160-749 | 1 |
465 | 1600mg | 1 |
466 | 165/95 | 1 |
467 | 167/101 | 1 |
468 | 169-erbium | 1 |
469 | 17,980 | 1 |
470 | 17-one | 1 |
471 | 171.0/94.3 | 1 |
472 | 172.3/104.3 | 1 |
473 | 175/116 | 1 |
474 | 177-247 | 1 |
475 | 18.9±3.0 | 1 |
476 | 18/370 | 1 |
477 | 19.5±11.8 | 1 |
478 | 1:6:6 | 1 |
479 | 2,3-dihydroxynaphthalene | 1 |
480 | 2,4-diacyl-2-hydroxylmethyl-2,3-dihydrofuran | 1 |
481 | 2-deoxy-glucopyranosyl | 1 |
482 | 2.1/0.1/0.26 | 1 |
483 | 2.10±0.63 | 1 |
484 | 2.2-80 | 1 |
485 | 2.24,95 | 1 |
486 | 2.280 | 1 |
487 | 2.378 | 1 |
488 | 2.41-3.07 | 1 |
489 | 2.41-5.21 | 1 |
490 | 2.475 | 1 |
491 | 2.6-4 | 1 |
492 | 2.642 | 1 |
493 | 2.67±0.87 | 1 |
494 | 2.960 | 1 |
495 | 20.3-17.6-28.0 | 1 |
496 | 20.7±25.5 | 1 |
497 | 200,000-600,000 | 1 |
498 | 20–25 | 1 |
499 | 21,505 | 1 |
500 | 210mg/min/person | 1 |
501 | 212°f | 1 |
502 | 216.46 | 1 |
503 | 22.28±7.31 | 1 |
504 | 22600 | 1 |
505 | 23.5+/-2.8 | 1 |
506 | 23±5.5 | 1 |
507 | 24-79 | 1 |
508 | 24.2mg | 1 |
509 | 25,335 | 1 |
510 | 25-700 | 1 |
511 | 25.5-64 | 1 |
512 | 25/116 | 1 |
513 | 25/250 | 1 |
514 | 252.2 | 1 |
515 | 25en | 1 |
516 | 27-29.9 | 1 |
517 | 27-minute | 1 |
518 | 27.1±7.6 | 1 |
519 | 27/79 | 1 |
520 | 28,3330 | 1 |
521 | 29-113 | 1 |
522 | 290.3 | 1 |
523 | 2rda-e | 1 |
524 | 2ν12 | 1 |
525 | 3,4-dihydroquinolin-2-ones | 1 |
526 | 3-consecutive | 1 |
527 | 3-glutathionyl-1,4-dihydroxy-5,8-dimethoxynaphthalenes | 1 |
528 | 3-hydroxy-3-hydroxymethyloxindoles | 1 |
529 | 3-hydroxycotinine/cotinine | 1 |
530 | 3.0-10 | 1 |
531 | 3.060 | 1 |
532 | 3.075 | 1 |
533 | 3.119 | 1 |
534 | 3.37-5.70 | 1 |
535 | 3.48+/-0.67 | 1 |
536 | 3.5-μmol/l | 1 |
537 | 3.5±1.2 | 1 |
538 | 3.76-15.22 | 1 |
539 | 30.0+/-3.0 | 1 |
540 | 30.1-33.5 | 1 |
541 | 300-500mg/dl | 1 |
542 | 300-799 | 1 |
543 | 31+/-12 | 1 |
544 | 31-180 | 1 |
545 | 31.9-34.2 | 1 |
546 | 312.0-319 | 1 |
547 | 33,547 | 1 |
548 | 33/11 | 1 |
549 | 35.2±6.8 | 1 |
550 | 35.6+/-10.2 | 1 |
551 | 35.6-49 | 1 |
552 | 35/20 | 1 |
553 | 35/366 | 1 |
554 | 350-650 | 1 |
555 | 35b | 1 |
556 | 36.310 | 1 |
557 | 37.8-64.3 | 1 |
558 | 375.00 | 1 |
559 | 38,631 | 1 |
560 | 38.9=10.6 | 1 |
561 | 38·4-89·4 | 1 |
562 | 39.70 | 1 |
563 | 39.9+/-4.3 | 1 |
564 | 3900/79 | 1 |
565 | 398.91 | 1 |
566 | 3rd/4th | 1 |
567 | 4,5-dehydrogeranyl | 1 |
568 | 4-methyl-thiazolyl | 1 |
569 | 4-methylpyridine | 1 |
570 | 4-phenyl-2-butanol | 1 |
571 | 4.13-25 | 1 |
572 | 4.6+/-1.7 | 1 |
573 | 4.7-4.9 | 1 |
574 | 4.715 | 1 |
575 | 4.8-18.9 | 1 |
576 | 4.801 | 1 |
577 | 4/+4/+ | 1 |
578 | 40-250 | 1 |
579 | 400-50 | 1 |
580 | 40en | 1 |
581 | 41.1-70.1 | 1 |
582 | 42.6+/-0.3 | 1 |
583 | 42.7±1.5 | 1 |
584 | 43-95 | 1 |
585 | 43.3±4.1 | 1 |
586 | 431.8 | 1 |
587 | 440.9 | 1 |
588 | 45/group | 1 |
589 | 48.0±4.0 | 1 |
590 | 480-500 | 1 |
591 | 5.1-15 | 1 |
592 | 5.1-7 | 1 |
593 | 5.128 | 1 |
594 | 5.136 | 1 |
595 | 5.23±0.51 | 1 |
596 | 5.76/1 | 1 |
597 | 5.917 | 1 |
598 | 50.6±34.2 | 1 |
599 | 500-1000mg/dl | 1 |
600 | 50±8.0 | 1 |
601 | 51-150 | 1 |
602 | 5180 | 1 |
603 | 52-92 | 1 |
604 | 53.43 | 1 |
605 | 56.2+/-8.8 | 1 |
606 | 570-850 | 1 |
607 | 5ht₃ab | 1 |
608 | 5β-dihydrosteroids | 1 |
609 | 6,920 | 1 |
610 | 6-chloro-3-deazaadenine | 1 |
611 | 6-meal | 1 |
612 | 6.0/5.6 | 1 |
613 | 6.194 | 1 |
614 | 600mcg | 1 |
615 | 60mg/l | 1 |
616 | 62.8±8.5 | 1 |
617 | 63.63±10.05 | 1 |
618 | 63.9+/-10.2 | 1 |
619 | 64.12±0.11 | 1 |
620 | 65.0+/-20.6 | 1 |
621 | 65±40 | 1 |
622 | 66-58 | 1 |
623 | 66gy/33 | 1 |
624 | 7,122 | 1 |
625 | 7-hexanoyltaxol | 1 |
626 | 7.0-13.9 | 1 |
627 | 7.1-11 | 1 |
628 | 7.300 | 1 |
629 | 7.32-70.06 | 1 |
630 | 7.612 | 1 |
631 | 7.62±1.81 | 1 |
632 | 7.7±2.8 | 1 |
633 | 7.8-15.0 | 1 |
634 | 73.29±0.81 | 1 |
635 | 76-81 | 1 |
636 | 76.7°c | 1 |
637 | 79.88 | 1 |
638 | 8,070 | 1 |
639 | 8,978 | 1 |
640 | 8.416 | 1 |
641 | 8.455 | 1 |
642 | 8.8±3 | 1 |
643 | 8.9-40.6 | 1 |
644 | 80-42 | 1 |
645 | 820-8000 | 1 |
646 | 83.426 | 1 |
647 | 84-115 | 1 |
648 | 84.25±1.18 | 1 |
649 | 85.9-99 | 1 |
650 | 86.19 | 1 |
651 | 86.64 | 1 |
652 | 89.03±1.07 | 1 |
653 | 9,530 | 1 |
654 | 9.3/4.9 | 1 |
655 | 9.5±1.1 | 1 |
656 | 90-112.5 | 1 |
657 | 9097 | 1 |
658 | 91.2-83.8 | 1 |
659 | 91.8/73.6 | 1 |
660 | 92.8/63.2 | 1 |
661 | 97-99.9 | 1 |
662 | 97/50 | 1 |
663 | 98/55 | 1 |
664 | 99.46 | 1 |
665 | 996.29 | 1 |
666 | :0.0014 | 1 |
667 | :0.028 | 1 |
668 | :0.596 | 1 |
669 | :1.28 | 1 |
670 | =-0.86 | 1 |
671 | =-1.38 | 1 |
672 | =-1·9 | 1 |
673 | =-21.98 | 1 |
674 | =-23.5 | 1 |
675 | =-5.5 | 1 |
676 | =-5.85 | 1 |
677 | =-6.8 | 1 |
678 | =.28 | 1 |
679 | =0.0009 | 1 |
680 | =0.06-2 | 1 |
681 | =0.157 | 1 |
682 | =0.1g/dl | 1 |
683 | =0.20-0.48 | 1 |
684 | =0.481 | 1 |
685 | =0.618 | 1 |
686 | =0° | 1 |
687 | =0·2 | 1 |
688 | =1,337 | 1 |
689 | =1,452 | 1 |
690 | =1,699 | 1 |
691 | =1.1+/-0.11 | 1 |
692 | =1.60 | 1 |
693 | =1.9-4.1 | 1 |
694 | =10.5±4.8 | 1 |
695 | =100-fold | 1 |
696 | =1024 | 1 |
697 | =103 | 1 |
698 | =1038 | 1 |
699 | =106 | 1 |
700 | =106.1 | 1 |
701 | =112 | 1 |
702 | =1140 | 1 |
703 | =1143 | 1 |
704 | =115/75 | 1 |
705 | =116 | 1 |
706 | =1207 | 1 |
707 | =122 | 1 |
708 | =124 | 1 |
709 | =130/85 | 1 |
710 | =134.97 | 1 |
711 | =135/85 | 1 |
712 | =138 | 1 |
713 | =138/84 | 1 |
714 | =1397 | 1 |
715 | =14.1 | 1 |
716 | =147 | 1 |
717 | =148 | 1 |
718 | =149 | 1 |
719 | =149.52 | 1 |
720 | =1500 | 1 |
721 | =152/98 | 1 |
722 | =154 | 1 |
723 | =158 | 1 |
724 | =159 | 1 |
725 | =16.5 | 1 |
726 | =162 | 1 |
727 | =162.2 | 1 |
728 | =164 | 1 |
729 | =172 | 1 |
730 | =179 | 1 |
731 | =18.87 | 1 |
732 | =180/110 | 1 |
733 | =188 | 1 |
734 | =19.8 | 1 |
735 | =196 | 1 |
736 | =198 | 1 |
737 | =199 | 1 |
738 | =1mg/kg/d | 1 |
739 | =2,000 | 1 |
740 | =2.17 | 1 |
741 | =2/4 | 1 |
742 | =20,180 | 1 |
743 | =20/50 | 1 |
744 | =2000 | 1 |
745 | =2023 | 1 |
746 | =210 | 1 |
747 | =2114 | 1 |
748 | =221 | 1 |
749 | =236 | 1 |
750 | =237 | 1 |
751 | =244 | 1 |
752 | =2440 | 1 |
753 | =245 | 1 |
754 | =25.3 | 1 |
755 | =25.5±2.7 | 1 |
756 | =2581 | 1 |
757 | =26,927 | 1 |
758 | =26.0 | 1 |
759 | =260 | 1 |
760 | =267 | 1 |
761 | =27.90 | 1 |
762 | =280 | 1 |
763 | =29.0 | 1 |
764 | =2h/day | 1 |
765 | =3- | 1 |
766 | =3.26 | 1 |
767 | =3.33 | 1 |
768 | =3.75-6.50 | 1 |
769 | =3/60 | 1 |
770 | =3/year | 1 |
771 | =30.0 | 1 |
772 | =32.2 | 1 |
773 | =32.5 | 1 |
774 | =340 | 1 |
775 | =343 | 1 |
776 | =344 | 1 |
777 | =359 | 1 |
778 | =37.5degreesc | 1 |
779 | =37.8 | 1 |
780 | =38.0 | 1 |
781 | =38.1 | 1 |
782 | =38degreesc | 1 |
783 | =39.5 | 1 |
784 | =39.9±17.7 | 1 |
785 | =397 | 1 |
786 | =3a | 1 |
787 | =3g/day | 1 |
788 | =4.52 | 1 |
789 | =4.60 | 1 |
790 | =4.66 | 1 |
791 | =40.0 | 1 |
792 | =400000/microl | 1 |
793 | =443 | 1 |
794 | =444 | 1 |
795 | =44±12 | 1 |
796 | =460 | 1 |
797 | =480 | 1 |
798 | =493 | 1 |
799 | =5,701 | 1 |
800 | =5.30 | 1 |
801 | =5.36 | 1 |
802 | =5400 | 1 |
803 | =566 | 1 |
804 | =592 | 1 |
805 | =6,971 | 1 |
806 | =6-week | 1 |
807 | =6.20 | 1 |
808 | =6.21 | 1 |
809 | =6.24 | 1 |
810 | =63.9 | 1 |
811 | =639 | 1 |
812 | =653 | 1 |
813 | =658 | 1 |
814 | =66.4 | 1 |
815 | =7.76 | 1 |
816 | =73.0 | 1 |
817 | =73.7 | 1 |
818 | =75.0 | 1 |
819 | =77.1 | 1 |
820 | =792 | 1 |
821 | =7days | 1 |
822 | =843 | 1 |
823 | =855 | 1 |
824 | =8773 | 1 |
825 | =9.8 | 1 |
826 | =925 | 1 |
827 | =940 | 1 |
828 | =96.6 | 1 |
829 | =98.0 | 1 |
830 | =98.5 | 1 |
831 | =99 | 1 |
832 | =gi3 | 1 |
833 | =median | 1 |
834 | =t3 | 1 |
835 | =x3 | 1 |
836 | abzé | 1 |
837 | acemetacin | 1 |
838 | acetonitrile-2 | 1 |
839 | activ* | 1 |
840 | acup* | 1 |
841 | adenocarc* | 1 |
842 | adofen | 1 |
843 | age=21.9±4.2 | 1 |
844 | age=54.1 | 1 |
845 | age=58.1+/-11.5 | 1 |
846 | age=59.8+/-9.9 | 1 |
847 | age=62.4+/-8.9 | 1 |
848 | ages-mf100 | 1 |
849 | aggregation-degradation | 1 |
850 | agri-chemicals | 1 |
851 | air-packaged | 1 |
852 | akokobesa | 1 |
853 | al-mis | 1 |
854 | alcohol-interlock | 1 |
855 | aldh1a3 | 1 |
856 | alpist | 1 |
857 | aminotriazole | 1 |
858 | amlopdipine | 1 |
859 | amulet™ | 1 |
860 | and-1051 | 1 |
861 | aneurin* | 1 |
862 | anticoagulant-naïve | 1 |
863 | anxioly* | 1 |
864 | arenes/g | 1 |
865 | arg-113 | 1 |
866 | arg16-gly16 | 1 |
867 | arthrit* | 1 |
868 | aslavital* | 1 |
869 | ast-activity | 1 |
870 | at1g35580 | 1 |
871 | atenolol/hydrochlorothiazide/trandolapril | 1 |
872 | avoid/non-avoid | 1 |
873 | awnings | 1 |
874 | barocaloric | 1 |
875 | basdai-levels | 1 |
876 | bathhouses | 1 |
877 | bcr/antigen | 1 |
878 | bed* | 1 |
879 | bedoon | 1 |
880 | beta-keratin | 1 |
881 | bg/gtr | 1 |
882 | bicycled | 1 |
883 | bifocus | 1 |
884 | biotically | 1 |
885 | blood-62 | 1 |
886 | bnp≥285 | 1 |
887 | bolheal | 1 |
888 | both.for | 1 |
889 | box-ii | 1 |
890 | brathytherapy | 1 |
891 | bsc+sunitinib | 1 |
892 | bucking/caught | 1 |
893 | c14h10 | 1 |
894 | ca-blockers | 1 |
895 | carcinom* | 1 |
896 | carrageenate | 1 |
897 | cd+zn+se | 1 |
898 | cd3/cd4 | 1 |
899 | cdab | 1 |
900 | cdg-ib | 1 |
901 | cd→g | 1 |
902 | cellulose/glucose | 1 |
903 | cervicoscopy | 1 |
904 | cessat* | 1 |
905 | cfl/glabellar | 1 |
906 | characteristic-based | 1 |
907 | chemoradio | 1 |
908 | chlorprotixine | 1 |
909 | chocholtecs | 1 |
910 | chr-nc=388 | 1 |
911 | chuchuaso | 1 |
912 | ci90 | 1 |
913 | cibalith-s | 1 |
914 | cisplatin-cumulative | 1 |
915 | cl-tai | 1 |
916 | clitoridectomia | 1 |
917 | clomi- | 1 |
918 | clonidine/naltrexone | 1 |
919 | clorgiline | 1 |
920 | clothiapine | 1 |
921 | clou | 1 |
922 | cn3 | 1 |
923 | co-depressed | 1 |
924 | combinations/augmentations | 1 |
925 | complete/repair | 1 |
926 | condition-induced | 1 |
927 | cow-milk-protein | 1 |
928 | cpap-devices | 1 |
929 | cross-columnar | 1 |
930 | crosseal | 1 |
931 | csld/bronchiectasis | 1 |
932 | ctx-m-27 | 1 |
933 | cycle* | 1 |
934 | cyclic-po4 | 1 |
935 | cyclic/control | 1 |
936 | cyp2d6*2 | 1 |
937 | d254a | 1 |
938 | damnation | 1 |
939 | dark-purple | 1 |
940 | dbp≥90 | 1 |
941 | dddr-60 | 1 |
942 | death-with | 1 |
943 | deculturation | 1 |
944 | delayed-recovery | 1 |
945 | deltafpg | 1 |
946 | dermatology-oncology | 1 |
947 | desensiti*ation | 1 |
948 | dexibruprofen | 1 |
949 | diazotrophy | 1 |
950 | diet+drugs | 1 |
951 | diff-quick™ | 1 |
952 | difference=7.5 | 1 |
953 | diflusinal | 1 |
954 | dihydroxycholecalciferols | 1 |
955 | discograms | 1 |
956 | disk* | 1 |
957 | dispersant-exposed | 1 |
958 | disulfide- | 1 |
959 | dk007571 | 1 |
960 | doc/pc | 1 |
961 | docutrix | 1 |
962 | dual-mixed | 1 |
963 | dudhi | 1 |
964 | dysthym* | 1 |
965 | dysynergistically | 1 |
966 | d≥30 | 1 |
967 | d≥32 | 1 |
968 | e138a | 1 |
969 | econazole- | 1 |
970 | eight-digit | 1 |
971 | elfra-2 | 1 |
972 | endur* | 1 |
973 | enox1 | 1 |
974 | enoxaparina | 1 |
975 | enthalpy-entropy-driven | 1 |
976 | er-her2- | 1 |
977 | erocap | 1 |
978 | et/dn | 1 |
979 | etiology-unknown | 1 |
980 | eucheuma | 1 |
981 | eusaprim | 1 |
982 | ex-usa | 1 |
983 | exapted | 1 |
984 | exemestene | 1 |
985 | exert* | 1 |
986 | f12.2 | 1 |
987 | fam22b | 1 |
988 | fed-pair | 1 |
989 | females/pen | 1 |
990 | fibringluraas | 1 |
991 | fitness* | 1 |
992 | flattering | 1 |
993 | flexknife | 1 |
994 | flubu | 1 |
995 | fluctin | 1 |
996 | fluctine | 1 |
997 | fluoropentyne | 1 |
998 | fluoxeren | 1 |
999 | flupirtin | 1 |
1000 | flutter/pacemaker | 1 |
1001 | fockian | 1 |
1002 | follow* | 1 |
1003 | fontex | 1 |
1004 | foradile | 1 |
1005 | fruitafit | 1 |
1006 | fujianese | 1 |
1007 | g1/g2-m | 1 |
1008 | gal3st3 | 1 |
1009 | gamma110 | 1 |
1010 | gh7 | 1 |
1011 | gingilone | 1 |
1012 | ginsenol | 1 |
1013 | ginsenoside* | 1 |
1014 | glucocorticoid* | 1 |
1015 | glycoprotein-receptoriib/iiia-antagonists | 1 |
1016 | gmfad8-1/gmfad8-2 | 1 |
1017 | gpqgiagq | 1 |
1018 | gr.iii | 1 |
1019 | greater-than-or-equal12 | 1 |
1020 | gus-hsf | 1 |
1021 | h-clinic | 1 |
1022 | h2/n1co | 1 |
1023 | hams40 | 1 |
1024 | hbv-as02 | 1 |
1025 | hct-trab | 1 |
1026 | hemoglobinsβ°-thalassemia | 1 |
1027 | her2-inhibitors | 1 |
1028 | herrings | 1 |
1029 | history/findings | 1 |
1030 | hmp50 | 1 |
1031 | homoeopath* | 1 |
1032 | hr80 | 1 |
1033 | hydroa | 1 |
1034 | hydrolystate | 1 |
1035 | hydroxydeoxyguanosine | 1 |
1036 | hyper-beta-lipoproteinemia | 1 |
1037 | hyper-methylated | 1 |
1038 | hyper-phosphatemia | 1 |
1039 | hyperphenomena | 1 |
1040 | hypersensation | 1 |
1041 | i-dose | 1 |
1042 | i.time | 1 |
1043 | i46.1 | 1 |
1044 | ic50=0.06 | 1 |
1045 | ic50~28.8 | 1 |
1046 | iff.drinking | 1 |
1047 | ifn-λ1 | 1 |
1048 | ihc2+/fluorescence | 1 |
1049 | iiia/m0 | 1 |
1050 | iiix3 | 1 |
1051 | il-1f11 | 1 |
1052 | immersion-chilled | 1 |
1053 | improvement=12·0 | 1 |
1054 | improvement=19·8 | 1 |
1055 | improvement=2·4 | 1 |
1056 | improvement=3·9 | 1 |
1057 | improvement=5·8 | 1 |
1058 | improvement=7·9 | 1 |
1059 | inhal* | 1 |
1060 | inogatran | 1 |
1061 | insulin±metformin | 1 |
1062 | inter-clonal | 1 |
1063 | interferon-intolerant | 1 |
1064 | interleukin-2-activated | 1 |
1065 | intimidation/pressure | 1 |
1066 | iodoinsulin | 1 |
1067 | iop≥50 | 1 |
1068 | is5 | 1 |
1069 | italy.1 | 1 |
1070 | ivus-measured | 1 |
1071 | jetamul-pleung-dang | 1 |
1072 | jmjd1a | 1 |
1073 | k-sensitive | 1 |
1074 | k117+k122 | 1 |
1075 | k2p9.1 | 1 |
1076 | kh3 | 1 |
1077 | kidney-failure | 1 |
1078 | kit-6 | 1 |
1079 | kugancao | 1 |
1080 | la-hs | 1 |
1081 | la-ls | 1 |
1082 | lactoalbumin | 1 |
1083 | ladose | 1 |
1084 | lagoonal | 1 |
1085 | laryngofibroscopy | 1 |
1086 | ldhi—lower | 1 |
1087 | led-1,500 | 1 |
1088 | leningrad-zagreb | 1 |
1089 | leponex* | 1 |
1090 | light-therapy | 1 |
1091 | light/ae | 1 |
1092 | light/tu | 1 |
1093 | lighting/ae | 1 |
1094 | linen* | 1 |
1095 | lip-licking | 1 |
1096 | lipidil | 1 |
1097 | lithane | 1 |
1098 | lithicarb | 1 |
1099 | lithobid | 1 |
1100 | loading→0.02 | 1 |
1101 | loading→0.04 | 1 |
1102 | locarbacef | 1 |
1103 | lomwe | 1 |
1104 | loofah | 1 |
1105 | lorien | 1 |
1106 | lovasta | 1 |
1107 | low-17 | 1 |
1108 | low-enthalpy | 1 |
1109 | low-tar/low-nicotine | 1 |
1110 | lumens/2.881 | 1 |
1111 | luminal/proximal | 1 |
1112 | luminex™ | 1 |
1113 | luteoliflavan | 1 |
1114 | lynestrol | 1 |
1115 | m0,3 | 1 |
1116 | map≤65 | 1 |
1117 | maxaquine | 1 |
1118 | mbpp | 1 |
1119 | medopa | 1 |
1120 | mensibisib | 1 |
1121 | mepyramine | 1 |
1122 | metastase | 1 |
1123 | methyldiphenylphosphine | 1 |
1124 | metreurynter | 1 |
1125 | metylperon | 1 |
1126 | mfc=0.098 | 1 |
1127 | micamycin | 1 |
1128 | micro-injuries | 1 |
1129 | microerosions | 1 |
1130 | mid-to-low | 1 |
1131 | midsubstance | 1 |
1132 | minocycline-rifampin-impregnated | 1 |
1133 | mir-146a*g | 1 |
1134 | mm/3 | 1 |
1135 | monthes | 1 |
1136 | months-80 | 1 |
1137 | motivat* | 1 |
1138 | moxicillin | 1 |
1139 | mph+ld | 1 |
1140 | muco-regulators | 1 |
1141 | muddled | 1 |
1142 | multi-skilling | 1 |
1143 | n-hexanol | 1 |
1144 | n-mers | 1 |
1145 | n-vacancies | 1 |
1146 | near-equivalent | 1 |
1147 | neoplasm* | 1 |
1148 | nevirapine+zidovudine/lamivudine | 1 |
1149 | nevirapine-nvp | 1 |
1150 | nicotine-administered | 1 |
1151 | nifedipine-atenolol | 1 |
1152 | nissen/gt | 1 |
1153 | nnips | 1 |
1154 | nocl | 1 |
1155 | non-attached | 1 |
1156 | non-citation | 1 |
1157 | non-communication | 1 |
1158 | non-complement | 1 |
1159 | non-hood | 1 |
1160 | non-linearities | 1 |
1161 | non-ordered | 1 |
1162 | non-spacer | 1 |
1163 | non-swimming | 1 |
1164 | non-verterbal | 1 |
1165 | nonbad | 1 |
1166 | nonheparin-bonded | 1 |
1167 | not-prescribed-when-unwarranted | 1 |
1168 | not… | 1 |
1169 | novocain* | 1 |
1170 | np-a50-fs | 1 |
1171 | nsmri | 1 |
1172 | nstami | 1 |
1173 | ntagonists | 1 |
1174 | ntde | 1 |
1175 | nuelin | 1 |
1176 | o-cmeth-yl | 1 |
1177 | o-hydroxylate | 1 |
1178 | o-mo | 1 |
1179 | o=0.098 | 1 |
1180 | obese.we | 1 |
1181 | observe/investigate | 1 |
1182 | oculomotor-leads | 1 |
1183 | orthonovum | 1 |
1184 | other-therapies | 1 |
1185 | otherwise.to | 1 |
1186 | otherworld | 1 |
1187 | otogeneous | 1 |
1188 | over-elaboration | 1 |
1189 | overcompliance | 1 |
1190 | p.r272pfsx35 | 1 |
1191 | p.w147x | 1 |
1192 | pain-induction/anger-induction | 1 |
1193 | panaxagin | 1 |
1194 | panaxoside* | 1 |
1195 | pandemrix® | 1 |
1196 | pansystole | 1 |
1197 | para-professional* | 1 |
1198 | partner-with-encouragement | 1 |
1199 | pd150606 | 1 |
1200 | peri-bronchovascular | 1 |
1201 | peruik | 1 |
1202 | pgf2α=40.3 | 1 |
1203 | phosphonacetyl-l-aspartate | 1 |
1204 | physical* | 1 |
1205 | phytomed* | 1 |
1206 | pifithrin-µ | 1 |
1207 | pinacolone | 1 |
1208 | pinset | 1 |
1209 | placebo+opv | 1 |
1210 | placebo+reboxetine | 1 |
1211 | placebo-edoxaban | 1 |
1212 | placebo/nwp06 | 1 |
1213 | pleur* | 1 |
1214 | pneumotachograph/flow-trigger | 1 |
1215 | polyantigen | 1 |
1216 | post-20 | 1 |
1217 | postbinding | 1 |
1218 | ppd4-5mm | 1 |
1219 | pp≥84 | 1 |
1220 | practi* | 1 |
1221 | pre-gaming | 1 |
1222 | pre/post-change | 1 |
1223 | precolored | 1 |
1224 | pregd | 1 |
1225 | prejugal | 1 |
1226 | prf/fat | 1 |
1227 | procain* | 1 |
1228 | procarbazine/lomustine/vincristine | 1 |
1229 | progams | 1 |
1230 | propanolamines | 1 |
1231 | prosympathetic | 1 |
1232 | protein-55 | 1 |
1233 | protocolized-care | 1 |
1234 | protopanaxa* | 1 |
1235 | prozyn | 1 |
1236 | pseudo-cluster | 1 |
1237 | pt4pn0 | 1 |
1238 | q-banded | 1 |
1239 | qam-tid | 1 |
1240 | quenchability | 1 |
1241 | quilonum | 1 |
1242 | quinolin-6-yl | 1 |
1243 | r96.1 | 1 |
1244 | radiologist/resident | 1 |
1245 | rate-place | 1 |
1246 | ratio-or+/-95 | 1 |
1247 | re-registration | 1 |
1248 | reduce* | 1 |
1249 | reduct* | 1 |
1250 | reduction=25 | 1 |
1251 | refer* | 1 |
1252 | reflection/scattering | 1 |
1253 | regional/teaching | 1 |
1254 | rehabilitat* | 1 |
1255 | relapse* | 1 |
1256 | relational/indirect | 1 |
1257 | reliseal | 1 |
1258 | reneuron | 1 |
1259 | restroom | 1 |
1260 | reviews:1 | 1 |
1261 | rice/d | 1 |
1262 | risperdal* | 1 |
1263 | rr=2.4 | 1 |
1264 | rs-infection | 1 |
1265 | ryu-ha | 1 |
1266 | s526a | 1 |
1267 | saccarides | 1 |
1268 | saline/ondansetron | 1 |
1269 | sanzur | 1 |
1270 | sb0thal | 1 |
1271 | sbp⩾160 | 1 |
1272 | schinseng | 1 |
1273 | scooting | 1 |
1274 | self-mutilations | 1 |
1275 | sem/wdx | 1 |
1276 | seroquel* | 1 |
1277 | session* | 1 |
1278 | sf-il-1ra | 1 |
1279 | sga-c | 1 |
1280 | sh:10 | 1 |
1281 | sh:20 | 1 |
1282 | shinseng | 1 |
1283 | short-message-service | 1 |
1284 | signif- | 1 |
1285 | simvastatin-equivalent | 1 |
1286 | single-inhibitor | 1 |
1287 | sirna-akt | 1 |
1288 | slc4a2 | 1 |
1289 | smu-b | 1 |
1290 | snap-back | 1 |
1291 | snd1t5 | 1 |
1292 | snowy | 1 |
1293 | spd489 | 1 |
1294 | specularity | 1 |
1295 | spiroplatin | 1 |
1296 | sprays/100 | 1 |
1297 | squamipedia | 1 |
1298 | ssris-appear | 1 |
1299 | stablilized | 1 |
1300 | stammers | 1 |
1301 | state-effects | 1 |
1302 | steam-cooked | 1 |
1303 | stepping-up | 1 |
1304 | sterol/day | 1 |
1305 | stop*.alois | 1 |
1306 | stored-filtered | 1 |
1307 | subfascially/subcutaneously | 1 |
1308 | sur2 | 1 |
1309 | sur2b | 1 |
1310 | syringetin | 1 |
1311 | t6-t7 | 1 |
1312 | tang-min-ling-wan | 1 |
1313 | tanse-tansy | 1 |
1314 | taper* | 1 |
1315 | taper-down | 1 |
1316 | tarandus | 1 |
1317 | tbi+bmc | 1 |
1318 | tetavax® | 1 |
1319 | theotrim | 1 |
1320 | tim-3tg→tim-3tg | 1 |
1321 | tim-3tg→wt | 1 |
1322 | tinaquant | 1 |
1323 | tiotropium/salmeterol | 1 |
1324 | tm-mode | 1 |
1325 | to-be-stopped | 1 |
1326 | tonsil* | 1 |
1327 | torasemide-ir | 1 |
1328 | toxicogenicity | 1 |
1329 | traffickers | 1 |
1330 | tranquil* | 1 |
1331 | trans-12 | 1 |
1332 | treatments-0.1 | 1 |
1333 | tria | 1 |
1334 | trial* | 1 |
1335 | trial-2.2 | 1 |
1336 | trial-8 | 1 |
1337 | triazol | 1 |
1338 | tritonx-100 | 1 |
1339 | trofibial | 1 |
1340 | trychomes | 1 |
1341 | tselutin | 1 |
1342 | tsn-injection | 1 |
1343 | two-serving | 1 |
1344 | tyr-94 | 1 |
1345 | unformatted | 1 |
1346 | unpoled | 1 |
1347 | unproportional | 1 |
1348 | uroseptics | 1 |
1349 | v0=3.7 | 1 |
1350 | vasodepression | 1 |
1351 | veip | 1 |
1352 | venvanse | 1 |
1353 | vindesine-etoposide | 1 |
1354 | vitacel* | 1 |
1355 | vitagel | 1 |
1356 | volunt* | 1 |
1357 | water-vapour* | 1 |
1358 | wernicke* | 1 |
1359 | withdraw* | 1 |
1360 | wmd=-100.82 | 1 |
1361 | y321f | 1 |
1362 | years-9.99 | 1 |
1363 | zadaxin | 1 |
1364 | zalain | 1 |
1365 | zeldox* | 1 |
1366 | zerit | 1 |
1367 | zygaena | 1 |
1368 | zyprexa* | 1 |
1369 | ~0.03 | 1 |
1370 | ~46-55 | 1 |
1371 | ~80-90 | 1 |
1372 | ~9160 | 1 |
1373 | £640,000 | 1 |
1374 | £70 | 1 |
1375 | ¹¹c-gsk189254 | 1 |
1376 | »7 | 1 |
1377 | ¿slc12a3¿ | 1 |
1378 | ×qrs | 1 |
1379 | α-d-glcp | 1 |
1380 | β-flupenthixol | 1 |
1381 | γ-ketoenals | 1 |
1382 | γ-methyl | 1 |
1383 | ε-amino | 1 |
1384 | θ-zrp | 1 |
1385 | ‘dash | 1 |
1386 | €321 | 1 |
1387 | ∆smds | 1 |
1388 | ∼1,600 | 1 |
1389 | ∼17.4 | 1 |
1390 | ∼3.72-3.77 | 1 |
1391 | ≤-1.63 | 1 |
1392 | ≤0.10 | 1 |
1393 | ≤0.73 | 1 |
1394 | ≤1.95 | 1 |
1395 | ≤13.9 | 1 |
1396 | ≤15.5 | 1 |
1397 | ≤3.1 | 1 |
1398 | ≤700 | 1 |
1399 | ≥0.11 | 1 |
1400 | ≥10/15 | 1 |
1401 | ≥110/65 | 1 |
1402 | ≥125/75 | 1 |
1403 | ≥130/75 | 1 |
1404 | ≥160/90 | 1 |
1405 | ≥180/95 | 1 |
1406 | ≥1·7 | 1 |
1407 | ≥200-350 | 1 |
1408 | ≥300mg/24h | 1 |
1409 | ≥540 | 1 |
1410 | ≥56.5 | 1 |
1411 | ≥6/9 | 1 |
1412 | ≥7·8 | 1 |
1413 | ⩽3.0 | 1 |
1414 | ⩽30 | 1 |
1415 | ⩾140 | 1 |
1416 | ⩾210 | 1 |
1 | 'days | 3 |
2 | 'divya | 1 |
3 | 'headgear | 1 |
4 | 'musa-pelo | 1 |
5 | 'preferences | 2 |
6 | 'teflon'® | 1 |
7 | 'wheeze | 1 |
8 | +0.0678 | 1 |
9 | +1·1 | 1 |
10 | +rt=66 | 1 |
11 | ,165 | 1 |
12 | -.99 | 1 |
13 | -0.2±57 | 1 |
14 | -0.7±2.1/-1.6±1.2 | 1 |
15 | -1,186 | 1 |
16 | -10.3/-6.9 | 1 |
17 | -10.9±20.1 | 1 |
18 | -11.1±10.1 | 1 |
19 | -11.3±12.2 | 1 |
20 | -13.03 | 1 |
21 | -138.2 | 1 |
22 | -14.1/-8.7 | 1 |
23 | -14.2±20.1 | 1 |
24 | -16±1.7 | 1 |
25 | -16±8.7 | 1 |
26 | -18-antibody- | 1 |
27 | -18.1±12.2 | 1 |
28 | -18:3n-3 | 2 |
29 | -2-butoxymethyl | 1 |
30 | -2.1/-1.5 | 1 |
31 | -2.9±0.9 | 1 |
32 | -20.3±19.2 | 1 |
33 | -21.06 | 1 |
34 | -23.11 | 2 |
35 | -23.14 | 1 |
36 | -230 | 2 |
37 | -299.8 | 1 |
38 | -30.1/-19.0 | 1 |
39 | -31.38 | 1 |
40 | -32.4±8.3 | 1 |
41 | -32mg/day | 1 |
42 | -363mg/day | 1 |
43 | -38.4±2.8 | 1 |
44 | -4,072 | 1 |
45 | -551a | 2 |
46 | -8.4±8.7 | 1 |
47 | -9.76 | 2 |
48 | -90±154 | 1 |
49 | -arylalkyl | 1 |
50 | -dhpg | 4 |
51 | -doxepin | 1 |
52 | -fluoride-pet/ct | 1 |
53 | -imidapril | 1 |
54 | -insufflation | 1 |
55 | -sma | 2 |
56 | /+0.4 | 1 |
57 | /-1.9 | 1 |
58 | /0.35 | 1 |
59 | /13.8 | 2 |
60 | /5.7 | 1 |
61 | /f/kg=4.441 | 1 |
62 | /vf | 1 |
63 | 0.010-0.100 | 1 |
64 | 0.02-1.0 | 1 |
65 | 0.04-2.560 | 1 |
66 | 0.12,95 | 1 |
67 | 0.14-0.15 | 1 |
68 | 0.16-150 | 1 |
69 | 0.20-2.00 | 1 |
70 | 0.25mg/ | 1 |
71 | 0.28-0.50 | 1 |
72 | 0.32±0.027 | 1 |
73 | 0.33:95 | 1 |
74 | 0.35-0.40 | 2 |
75 | 0.39mmol/l | 1 |
76 | 0.5+ | 1 |
77 | 0.5-300 | 1 |
78 | 0.88,95 | 1 |
79 | 0.96-1.86 | 1 |
80 | 0·992 | 1 |
81 | 1,03 | 1 |
82 | 1,1,1-trichloropropene | 1 |
83 | 1,400-mg | 1 |
84 | 1,575°c | 1 |
85 | 1.0320 | 1 |
86 | 1.04,95 | 1 |
87 | 1.57-2.38 | 1 |
88 | 1.57±0.96 | 1 |
89 | 1.6±8.6 | 1 |
90 | 1.779 | 1 |
91 | 1.88/0.86 | 1 |
92 | 1.95-21.2 | 1 |
93 | 1.968 | 1 |
94 | 1/133 | 1 |
95 | 1/clearance | 1 |
96 | 10-11.1 | 2 |
97 | 10-13.4 | 1 |
98 | 10.46+/-1.24 | 1 |
99 | 10.46±3.8 | 1 |
100 | 105/80 | 1 |
101 | 106/5.9-48.7 | 1 |
102 | 107/52 | 1 |
103 | 108+/-37 | 1 |
104 | 109+/-11 | 1 |
105 | 10x10x3 | 1 |
106 | 11.0/8.1 | 1 |
107 | 11.108 | 1 |
108 | 11.2/8.5 | 1 |
109 | 11.20-55.60 | 1 |
110 | 115.14 | 1 |
111 | 12.9/7.7 | 1 |
112 | 12/diet | 1 |
113 | 120.99 | 1 |
114 | 120mg/d | 1 |
115 | 121-139/81-89 | 1 |
116 | 128±86 | 1 |
117 | 13.2/8.5 | 1 |
118 | 13.3/7.8 | 1 |
119 | 13.4±2.4 | 1 |
120 | 13.711 | 1 |
121 | 13.8-80.3 | 1 |
122 | 13.92±2.75 | 1 |
123 | 130-140/70-80 | 1 |
124 | 130/77 | 1 |
125 | 131/78 | 1 |
126 | 132.3/74.0 | 1 |
127 | 135-159 | 1 |
128 | 138.62 | 1 |
129 | 138.896 | 1 |
130 | 138±12 | 1 |
131 | 138±35 | 2 |
132 | 14.90±7.28 | 1 |
133 | 142-210 | 1 |
134 | 142/81 | 1 |
135 | 148-μg | 3 |
136 | 15-19.9 | 1 |
137 | 150.6/99.1 | 1 |
138 | 151-159/100-109 | 2 |
139 | 154±11 | 1 |
140 | 156.93 | 1 |
141 | 16.2-58.0 | 1 |
142 | 16.470 | 1 |
143 | 16.627 | 1 |
144 | 160-170 | 1 |
145 | 160-749 | 1 |
146 | 1600mg | 1 |
147 | 165/95 | 1 |
148 | 167/101 | 1 |
149 | 169-erbium | 1 |
150 | 17,980 | 1 |
151 | 17-one | 1 |
152 | 171.0/94.3 | 1 |
153 | 172.3/104.3 | 1 |
154 | 175/116 | 1 |
155 | 177-247 | 1 |
156 | 18.9±3.0 | 1 |
157 | 18/370 | 1 |
158 | 19.5±11.8 | 1 |
159 | 1:6:6 | 1 |
160 | 2,3-dihydroxynaphthalene | 1 |
161 | 2,4-diacyl-2-hydroxylmethyl-2,3-dihydrofuran | 1 |
162 | 2-deoxy-glucopyranosyl | 1 |
163 | 2.1/0.1/0.26 | 1 |
164 | 2.10±0.63 | 1 |
165 | 2.2-80 | 1 |
166 | 2.24,95 | 1 |
167 | 2.280 | 1 |
168 | 2.378 | 1 |
169 | 2.41-3.07 | 1 |
170 | 2.41-5.21 | 1 |
171 | 2.475 | 1 |
172 | 2.6-4 | 1 |
173 | 2.642 | 1 |
174 | 2.67±0.87 | 1 |
175 | 2.960 | 1 |
176 | 20.3-17.6-28.0 | 1 |
177 | 20.7±25.5 | 1 |
178 | 200,000-600,000 | 1 |
179 | 20–25 | 1 |
180 | 21,505 | 1 |
181 | 210mg/min/person | 1 |
182 | 212°f | 1 |
183 | 216.46 | 1 |
184 | 22.28±7.31 | 1 |
185 | 22600 | 1 |
186 | 23.5+/-2.8 | 1 |
187 | 23±5.5 | 1 |
188 | 24-79 | 1 |
189 | 24.2mg | 1 |
190 | 25,335 | 1 |
191 | 25-700 | 1 |
192 | 25.5-64 | 1 |
193 | 25/116 | 1 |
194 | 25/250 | 1 |
195 | 252.2 | 1 |
196 | 25en | 1 |
197 | 25·5 | 2 |
198 | 25×2×2 | 2 |
199 | 27-29.9 | 1 |
200 | 27-minute | 1 |
201 | 27.1±7.6 | 1 |
202 | 27/79 | 1 |
203 | 28,3330 | 1 |
204 | 29-113 | 1 |
205 | 290.3 | 1 |
206 | 2rda-e | 1 |
207 | 2ν12 | 1 |
208 | 3,4-dihydroquinolin-2-ones | 1 |
209 | 3-consecutive | 1 |
210 | 3-glutathionyl-1,4-dihydroxy-5,8-dimethoxynaphthalenes | 1 |
211 | 3-hydroxy-3-hydroxymethyloxindoles | 1 |
212 | 3-hydroxycotinine/cotinine | 1 |
213 | 3.0-10 | 1 |
214 | 3.060 | 1 |
215 | 3.075 | 1 |
216 | 3.119 | 1 |
217 | 3.2-3.8 | 2 |
218 | 3.37-5.70 | 1 |
219 | 3.48+/-0.67 | 1 |
220 | 3.5-μmol/l | 1 |
221 | 3.5±1.2 | 1 |
222 | 3.76-15.22 | 1 |
223 | 30.0+/-3.0 | 1 |
224 | 30.1-33.5 | 1 |
225 | 30.62 | 2 |
226 | 300-500mg/dl | 1 |
227 | 300-799 | 1 |
228 | 31+/-12 | 1 |
229 | 31-180 | 1 |
230 | 31.9-34.2 | 1 |
231 | 312.0-319 | 1 |
232 | 33,547 | 1 |
233 | 33/11 | 1 |
234 | 34.74 | 2 |
235 | 35.2±6.8 | 1 |
236 | 35.6+/-10.2 | 1 |
237 | 35.6-49 | 1 |
238 | 35/20 | 1 |
239 | 35/366 | 1 |
240 | 350-650 | 1 |
241 | 35b | 1 |
242 | 36.310 | 1 |
243 | 37.8-64.3 | 1 |
244 | 375.00 | 1 |
245 | 38,631 | 1 |
246 | 38.9=10.6 | 1 |
247 | 38·4-89·4 | 1 |
248 | 39.70 | 1 |
249 | 39.9+/-4.3 | 1 |
250 | 3900/79 | 1 |
251 | 398.91 | 1 |
252 | 3rd/4th | 1 |
253 | 3x/wk | 2 |
254 | 4,5-dehydrogeranyl | 1 |
255 | 4-methyl-thiazolyl | 1 |
256 | 4-methylpyridine | 1 |
257 | 4-phenyl-2-butanol | 1 |
258 | 4.13-25 | 1 |
259 | 4.6+/-1.7 | 1 |
260 | 4.7-4.9 | 1 |
261 | 4.715 | 1 |
262 | 4.8-18.9 | 1 |
263 | 4.801 | 1 |
264 | 4/+4/+ | 1 |
265 | 40-250 | 1 |
266 | 400-50 | 1 |
267 | 40en | 1 |
268 | 41.1-70.1 | 1 |
269 | 42.6+/-0.3 | 1 |
270 | 42.7±1.5 | 1 |
271 | 43-95 | 1 |
272 | 43.3±4.1 | 1 |
273 | 431.8 | 1 |
274 | 440.9 | 1 |
275 | 45/group | 1 |
276 | 4776 | 2 |
277 | 48.0±4.0 | 1 |
278 | 480-500 | 1 |
279 | 5.1-15 | 1 |
280 | 5.1-7 | 1 |
281 | 5.128 | 1 |
282 | 5.136 | 1 |
283 | 5.23±0.51 | 1 |
284 | 5.76/1 | 1 |
285 | 5.917 | 1 |
286 | 50.6±34.2 | 1 |
287 | 500-1000mg/dl | 1 |
288 | 50±8.0 | 1 |
289 | 51-150 | 1 |
290 | 5180 | 1 |
291 | 52-92 | 1 |
292 | 53.43 | 1 |
293 | 56.2+/-8.8 | 1 |
294 | 570-850 | 1 |
295 | 5ht₃ab | 1 |
296 | 5·11 | 2 |
297 | 5β-dihydrosteroids | 1 |
298 | 6,920 | 1 |
299 | 6-chloro-3-deazaadenine | 1 |
300 | 6-meal | 1 |
301 | 6.0/5.6 | 1 |
302 | 6.194 | 1 |
303 | 600mcg | 1 |
304 | 60mg/l | 1 |
305 | 62.8±8.5 | 1 |
306 | 63.63±10.05 | 1 |
307 | 63.9+/-10.2 | 1 |
308 | 64.12±0.11 | 1 |
309 | 65.0+/-20.6 | 1 |
310 | 65±40 | 1 |
311 | 65·8 | 2 |
312 | 66-58 | 1 |
313 | 66gy/33 | 1 |
314 | 69.05 | 2 |
315 | 7+/-18 | 2 |
316 | 7,122 | 1 |
317 | 7-hexanoyltaxol | 1 |
318 | 7.0-13.9 | 1 |
319 | 7.1-11 | 1 |
320 | 7.300 | 1 |
321 | 7.32-70.06 | 1 |
322 | 7.612 | 1 |
323 | 7.62±1.81 | 1 |
324 | 7.7±2.8 | 1 |
325 | 7.8-15.0 | 1 |
326 | 71.04 | 2 |
327 | 73.29±0.81 | 1 |
328 | 75+/-8 | 2 |
329 | 76-81 | 1 |
330 | 76.7°c | 1 |
331 | 77.07 | 2 |
332 | 79.88 | 1 |
333 | 8,070 | 1 |
334 | 8,978 | 1 |
335 | 8-5 | 4 |
336 | 8.416 | 1 |
337 | 8.455 | 1 |
338 | 8.8±3 | 1 |
339 | 8.9-40.6 | 1 |
340 | 80-42 | 1 |
341 | 820-8000 | 1 |
342 | 83.426 | 1 |
343 | 84-115 | 1 |
344 | 84.25±1.18 | 1 |
345 | 85.9-99 | 1 |
346 | 86.19 | 1 |
347 | 86.64 | 1 |
348 | 89.03±1.07 | 1 |
349 | 8·16 | 2 |
350 | 8×9 | 2 |
351 | 9,530 | 1 |
352 | 9.3/4.9 | 1 |
353 | 9.5±1.1 | 1 |
354 | 90-112.5 | 1 |
355 | 9097 | 1 |
356 | 91.2-83.8 | 1 |
357 | 91.8/73.6 | 1 |
358 | 92.8/63.2 | 1 |
359 | 97-99.9 | 1 |
360 | 97/50 | 1 |
361 | 98/55 | 1 |
362 | 99.46 | 1 |
363 | 996.29 | 1 |
364 | :0.0014 | 1 |
365 | :0.028 | 1 |
366 | :0.596 | 1 |
367 | :1.28 | 1 |
368 | =-0.86 | 1 |
369 | =-1.0 | 2 |
370 | =-1.38 | 1 |
371 | =-1·9 | 1 |
372 | =-2.5 | 7 |
373 | =-21.98 | 1 |
374 | =-23.5 | 1 |
375 | =-3 | 3 |
376 | =-5.5 | 1 |
377 | =-5.85 | 1 |
378 | =-6.8 | 1 |
379 | =-9 | 2 |
380 | =.28 | 1 |
381 | =0.0009 | 1 |
382 | =0.06-2 | 1 |
383 | =0.1 | 21 |
384 | =0.157 | 1 |
385 | =0.1g/dl | 1 |
386 | =0.2 | 14 |
387 | =0.20-0.48 | 1 |
388 | =0.3 | 9 |
389 | =0.4 | 3 |
390 | =0.40 | 23 |
391 | =0.481 | 1 |
392 | =0.5 | 21 |
393 | =0.618 | 1 |
394 | =0.9 | 12 |
395 | =0° | 1 |
396 | =0·2 | 1 |
397 | =1 | 196 |
398 | =1,337 | 1 |
399 | =1,452 | 1 |
400 | =1,699 | 1 |
401 | =1.0 | 14 |
402 | =1.1 | 6 |
403 | =1.1+/-0.11 | 1 |
404 | =1.2 | 13 |
405 | =1.20 | 2 |
406 | =1.3 | 8 |
407 | =1.4 | 8 |
408 | =1.40 | 7 |
409 | =1.5 | 25 |
410 | =1.50 | 2 |
411 | =1.60 | 1 |
412 | =1.7 | 5 |
413 | =1.8 | 5 |
414 | =1.9 | 4 |
415 | =1.9-4.1 | 1 |
416 | =1/3 | 2 |
417 | =10 | 158 |
418 | =10,000 | 5 |
419 | =10-20 | 2 |
420 | =10.5 | 3 |
421 | =10.5±4.8 | 1 |
422 | =100 | 58 |
423 | =100,000 | 6 |
424 | =100-fold | 1 |
425 | =100.1 | 2 |
426 | =101 | 2 |
427 | =1024 | 1 |
428 | =103 | 1 |
429 | =1038 | 1 |
430 | =105 | 8 |
431 | =106 | 1 |
432 | =106.1 | 1 |
433 | =107 | 2 |
434 | =109 | 2 |
435 | =11 | 17 |
436 | =11.1 | 4 |
437 | =11.3 | 2 |
438 | =110 | 16 |
439 | =111 | 2 |
440 | =112 | 1 |
441 | =1140 | 1 |
442 | =1143 | 1 |
443 | =115 | 3 |
444 | =115/75 | 1 |
445 | =116 | 1 |
446 | =117 | 3 |
447 | =119 | 3 |
448 | =12 | 64 |
449 | =12.0 | 2 |
450 | =12.5 | 5 |
451 | =120 | 19 |
452 | =1207 | 1 |
453 | =122 | 1 |
454 | =123 | 2 |
455 | =124 | 1 |
456 | =125 | 4 |
457 | =126 | 5 |
458 | =13 | 20 |
459 | =130 | 28 |
460 | =130/80 | 2 |
461 | =130/85 | 1 |
462 | =132 | 3 |
463 | =133 | 2 |
464 | =134 | 2 |
465 | =134.97 | 1 |
466 | =135 | 5 |
467 | =135/85 | 1 |
468 | =138 | 1 |
469 | =138/84 | 1 |
470 | =1397 | 1 |
471 | =14 | 22 |
472 | =14.1 | 1 |
473 | =140 | 51 |
474 | =140/100 | 2 |
475 | =140/90 | 13 |
476 | =144 | 3 |
477 | =145 | 5 |
478 | =147 | 1 |
479 | =148 | 1 |
480 | =149 | 1 |
481 | =149.52 | 1 |
482 | =15 | 64 |
483 | =15,000 | 2 |
484 | =15/h | 2 |
485 | =150 | 23 |
486 | =1500 | 1 |
487 | =152/98 | 1 |
488 | =154 | 1 |
489 | =155 | 2 |
490 | =158 | 1 |
491 | =159 | 1 |
492 | =16 | 36 |
493 | =16.5 | 1 |
494 | =160 | 29 |
495 | =160/100 | 3 |
496 | =160/90 | 4 |
497 | =162 | 1 |
498 | =162.2 | 1 |
499 | =163 | 4 |
500 | =164 | 1 |
501 | =17 | 14 |
502 | =17.5 | 2 |
503 | =170 | 2 |
504 | =172 | 1 |
505 | =175 | 4 |
506 | =179 | 1 |
507 | =18 | 88 |
508 | =18.2 | 2 |
509 | =18.87 | 1 |
510 | =180 | 8 |
511 | =180/110 | 1 |
512 | =183 | 2 |
513 | =188 | 1 |
514 | =19 | 11 |
515 | =19.4 | 2 |
516 | =19.8 | 1 |
517 | =190 | 7 |
518 | =196 | 1 |
519 | =198 | 1 |
520 | =199 | 1 |
521 | =1mg/kg/d | 1 |
522 | =2 | 190 |
523 | =2+ | 4 |
524 | =2,000 | 1 |
525 | =2-min | 2 |
526 | =2.0 | 21 |
527 | =2.17 | 1 |
528 | =2.2 | 8 |
529 | =2.5 | 18 |
530 | =2.6 | 5 |
531 | =2.60 | 3 |
532 | =2.67 | 2 |
533 | =2.7 | 4 |
534 | =2/4 | 1 |
535 | =20 | 88 |
536 | =20,180 | 1 |
537 | =20/200 | 2 |
538 | =20/40 | 4 |
539 | =20/50 | 1 |
540 | =200 | 29 |
541 | =2000 | 1 |
542 | =2023 | 1 |
543 | =21 | 20 |
544 | =210 | 1 |
545 | =2114 | 1 |
546 | =22 | 11 |
547 | =220 | 5 |
548 | =221 | 1 |
549 | =23 | 10 |
550 | =236 | 1 |
551 | =237 | 1 |
552 | =24 | 20 |
553 | =24.9 | 2 |
554 | =240 | 8 |
555 | =244 | 1 |
556 | =2440 | 1 |
557 | =245 | 1 |
558 | =25 | 69 |
559 | =25.2 | 3 |
560 | =25.3 | 1 |
561 | =25.5±2.7 | 1 |
562 | =250 | 10 |
563 | =2581 | 1 |
564 | =26 | 15 |
565 | =26,927 | 1 |
566 | =26.0 | 1 |
567 | =26.5 | 2 |
568 | =260 | 1 |
569 | =267 | 1 |
570 | =27 | 9 |
571 | =27.5 | 2 |
572 | =27.90 | 1 |
573 | =28 | 13 |
574 | =280 | 1 |
575 | =29 | 12 |
576 | =29.0 | 1 |
577 | =2h/day | 1 |
578 | =3 | 185 |
579 | =3,000 | 2 |
580 | =3- | 1 |
581 | =3.0 | 15 |
582 | =3.09 | 2 |
583 | =3.2 | 5 |
584 | =3.26 | 1 |
585 | =3.3 | 2 |
586 | =3.33 | 1 |
587 | =3.36 | 2 |
588 | =3.4 | 3 |
589 | =3.5 | 11 |
590 | =3.75-6.50 | 1 |
591 | =3.88 | 2 |
592 | =3/60 | 1 |
593 | =3/year | 1 |
594 | =30 | 138 |
595 | =30.0 | 1 |
596 | =300 | 12 |
597 | =31 | 7 |
598 | =32 | 15 |
599 | =32.2 | 1 |
600 | =32.5 | 1 |
601 | =33 | 16 |
602 | =34 | 11 |
603 | =340 | 1 |
604 | =343 | 1 |
605 | =344 | 1 |
606 | =35 | 69 |
607 | =350 | 7 |
608 | =359 | 1 |
609 | =36 | 14 |
610 | =36.1 | 2 |
611 | =37 | 15 |
612 | =37.5degreesc | 1 |
613 | =37.8 | 1 |
614 | =38 | 13 |
615 | =38.0 | 1 |
616 | =38.1 | 1 |
617 | =38degreesc | 1 |
618 | =39 | 8 |
619 | =39.5 | 1 |
620 | =39.9±17.7 | 1 |
621 | =397 | 1 |
622 | =3a | 1 |
623 | =3g/day | 1 |
624 | =4 | 96 |
625 | =4.0 | 11 |
626 | =4.14 | 2 |
627 | =4.17 | 2 |
628 | =4.20 | 2 |
629 | =4.5 | 10 |
630 | =4.52 | 1 |
631 | =4.60 | 1 |
632 | =4.66 | 1 |
633 | =40 | 135 |
634 | =40.0 | 1 |
635 | =400 | 12 |
636 | =400000/microl | 1 |
637 | =41 | 9 |
638 | =42 | 3 |
639 | =43 | 3 |
640 | =44 | 6 |
641 | =443 | 1 |
642 | =444 | 1 |
643 | =44±12 | 1 |
644 | =45 | 63 |
645 | =460 | 1 |
646 | =47 | 10 |
647 | =48 | 18 |
648 | =480 | 1 |
649 | =493 | 1 |
650 | =5 | 122 |
651 | =5,701 | 1 |
652 | =5,759 | 2 |
653 | =5.17 | 2 |
654 | =5.2 | 6 |
655 | =5.30 | 1 |
656 | =5.36 | 1 |
657 | =5.5 | 10 |
658 | =5.6 | 9 |
659 | =5/10 | 2 |
660 | =500 | 15 |
661 | =500/microl | 2 |
662 | =5000 | 4 |
663 | =51 | 5 |
664 | =52 | 9 |
665 | =54 | 4 |
666 | =5400 | 1 |
667 | =55 | 34 |
668 | =56 | 7 |
669 | =566 | 1 |
670 | =57 | 6 |
671 | =59 | 4 |
672 | =592 | 1 |
673 | =6 | 83 |
674 | =6,971 | 1 |
675 | =6-week | 1 |
676 | =6.0 | 6 |
677 | =6.2 | 6 |
678 | =6.20 | 1 |
679 | =6.21 | 1 |
680 | =6.24 | 1 |
681 | =6.5 | 12 |
682 | =60 | 115 |
683 | =600 | 3 |
684 | =62.5 | 2 |
685 | =63.9 | 1 |
686 | =639 | 1 |
687 | =64 | 8 |
688 | =65 | 128 |
689 | =65.0 | 2 |
690 | =653 | 1 |
691 | =658 | 1 |
692 | =66.4 | 1 |
693 | =67 | 11 |
694 | =69 | 10 |
695 | =7 | 98 |
696 | =7.0 | 6 |
697 | =7.4 | 2 |
698 | =7.5 | 7 |
699 | =7.76 | 1 |
700 | =7.8 | 7 |
701 | =70 | 94 |
702 | =700 | 3 |
703 | =71 | 3 |
704 | =72 | 18 |
705 | =73 | 5 |
706 | =73.0 | 1 |
707 | =73.7 | 1 |
708 | =74 | 4 |
709 | =75 | 45 |
710 | =75.0 | 1 |
711 | =75th | 3 |
712 | =76 | 6 |
713 | =77.1 | 1 |
714 | =78 | 5 |
715 | =792 | 1 |
716 | =7days | 1 |
717 | =8 | 55 |
718 | =8.0 | 2 |
719 | =8.7 | 2 |
720 | =80 | 60 |
721 | =800 | 6 |
722 | =81 | 2 |
723 | =82 | 4 |
724 | =84 | 5 |
725 | =843 | 1 |
726 | =85 | 27 |
727 | =855 | 1 |
728 | =87 | 3 |
729 | =8773 | 1 |
730 | =88 | 3 |
731 | =89 | 4 |
732 | =9 | 24 |
733 | =9.0 | 3 |
734 | =9.8 | 1 |
735 | =90 | 55 |
736 | =91 | 4 |
737 | =925 | 1 |
738 | =94 | 2 |
739 | =940 | 1 |
740 | =95 | 10 |
741 | =96 | 6 |
742 | =96.6 | 1 |
743 | =97 | 4 |
744 | =98 | 4 |
745 | =98.0 | 1 |
746 | =98.5 | 1 |
747 | =99 | 1 |
748 | =cin2 | 5 |
749 | =cin3 | 8 |
750 | =ff=cap | 2 |
751 | =gi3 | 1 |
752 | =ii | 6 |
753 | =iii | 3 |
754 | =median | 1 |
755 | =t3 | 1 |
756 | =x3 | 1 |
757 | abzé | 1 |
758 | acemetacin | 1 |
759 | acetonitrile-2 | 1 |
760 | activ* | 1 |
761 | acup* | 1 |
762 | adenocarc* | 1 |
763 | adhere* | 2 |
764 | admission* | 4 |
765 | adofen | 1 |
766 | age=21.9±4.2 | 1 |
767 | age=54.1 | 1 |
768 | age=58.1+/-11.5 | 1 |
769 | age=59.8+/-9.9 | 1 |
770 | age=62.4+/-8.9 | 1 |
771 | ages-mf100 | 1 |
772 | aggregation-degradation | 1 |
773 | agotf | 2 |
774 | agri-chemicals | 1 |
775 | air-packaged | 1 |
776 | akokobesa | 1 |
777 | al-mis | 1 |
778 | alcohol-interlock | 1 |
779 | aldh1a3 | 1 |
780 | alpist | 1 |
781 | aminophylline-treated | 3 |
782 | aminotriazole | 1 |
783 | amlopdipine | 1 |
784 | amnestic-mci | 2 |
785 | amulet™ | 1 |
786 | and-1051 | 1 |
787 | aneurin* | 1 |
788 | anh/ibr/pbr | 2 |
789 | anticoagulant-naïve | 1 |
790 | antimicrob* | 4 |
791 | anxioly* | 1 |
792 | arenes/g | 1 |
793 | arg-113 | 1 |
794 | arg130 | 2 |
795 | arg16-gly16 | 1 |
796 | arthrit* | 1 |
797 | aslavital* | 1 |
798 | ast-activity | 1 |
799 | asusto | 2 |
800 | at1g35580 | 1 |
801 | atenolol/hydrochlorothiazide/trandolapril | 1 |
802 | avoid/non-avoid | 1 |
803 | awnings | 1 |
804 | barocaloric | 1 |
805 | basdai-levels | 1 |
806 | bathhouses | 1 |
807 | bcr/antigen | 1 |
808 | bed* | 1 |
809 | bedoon | 1 |
810 | beta-hydroxylovastatin | 2 |
811 | beta-keratin | 1 |
812 | bg/gtr | 1 |
813 | bicycled | 1 |
814 | bifocus | 1 |
815 | biotically | 1 |
816 | blood-62 | 1 |
817 | bnp≥285 | 1 |
818 | bolheal | 1 |
819 | both.for | 1 |
820 | box-ii | 1 |
821 | bradyphrenia | 2 |
822 | brathytherapy | 1 |
823 | brush/spatula | 2 |
824 | bsc+sunitinib | 1 |
825 | bucking/caught | 1 |
826 | butyroyl-arginine | 2 |
827 | c14h10 | 1 |
828 | ca-blockers | 1 |
829 | carcinom* | 1 |
830 | carrageenate | 1 |
831 | cd+zn+se | 1 |
832 | cd3/cd4 | 1 |
833 | cd4-cd8+ | 2 |
834 | cdab | 1 |
835 | cdg-ib | 1 |
836 | cd→g | 1 |
837 | cellulose/glucose | 1 |
838 | cervicoscopy | 1 |
839 | cessat* | 1 |
840 | cfl/glabellar | 1 |
841 | characteristic-based | 1 |
842 | chemoradio | 1 |
843 | chlorprotixine | 1 |
844 | chocholtecs | 1 |
845 | chr-nc=388 | 1 |
846 | chuchuaso | 1 |
847 | ci90 | 1 |
848 | cibalith-s | 1 |
849 | cisplatin-cumulative | 1 |
850 | cl-tai | 1 |
851 | clec4d | 2 |
852 | clitoridectomia | 1 |
853 | clomi- | 1 |
854 | clonidine/naltrexone | 1 |
855 | clorgiline | 1 |
856 | clothiapine | 1 |
857 | clou | 1 |
858 | cn3 | 1 |
859 | co-depressed | 1 |
860 | co-produced | 2 |
861 | combinations/augmentations | 1 |
862 | complete/repair | 1 |
863 | condition-induced | 1 |
864 | convent* | 2 |
865 | corticosteroid* | 2 |
866 | cow-milk-protein | 1 |
867 | cpap-devices | 1 |
868 | cross-columnar | 1 |
869 | crosseal | 1 |
870 | csld/bronchiectasis | 1 |
871 | ctx-m-27 | 1 |
872 | cycle* | 1 |
873 | cyclic-po4 | 1 |
874 | cyclic/control | 1 |
875 | cyp2d6*2 | 1 |
876 | d254a | 1 |
877 | damnation | 1 |
878 | danc* | 2 |
879 | dark-purple | 1 |
880 | dbp≥90 | 1 |
881 | dddr-60 | 1 |
882 | death-with | 1 |
883 | deculturation | 1 |
884 | delayed-recovery | 1 |
885 | delphis | 2 |
886 | deltafpg | 1 |
887 | demand/semi | 2 |
888 | dermatology-oncology | 1 |
889 | desensiti*ation | 1 |
890 | dexibruprofen | 1 |
891 | diazotrophy | 1 |
892 | diet+drugs | 1 |
893 | diff-quick™ | 1 |
894 | difference=7.5 | 1 |
895 | diflusinal | 1 |
896 | dihydroxycholecalciferols | 1 |
897 | discograms | 1 |
898 | disk* | 1 |
899 | dispersant-exposed | 1 |
900 | disulfide- | 1 |
901 | dk007571 | 1 |
902 | doc/pc | 1 |
903 | docutrix | 1 |
904 | drink* | 2 |
905 | dropout* | 2 |
906 | dual-mixed | 1 |
907 | dual-treatment | 2 |
908 | dudhi | 1 |
909 | dysport™ | 2 |
910 | dysthym* | 1 |
911 | dysynergistically | 1 |
912 | d≥30 | 1 |
913 | d≥32 | 1 |
914 | e138a | 1 |
915 | econazole- | 1 |
916 | eight-digit | 1 |
917 | elfra-2 | 1 |
918 | elixophyllin | 2 |
919 | endomyoparametritis | 2 |
920 | endur* | 1 |
921 | enox1 | 1 |
922 | enoxaparina | 1 |
923 | enthalpy-entropy-driven | 1 |
924 | equal | 5,791 |
925 | er-her2- | 1 |
926 | erocap | 1 |
927 | et/dn | 1 |
928 | ethibond™ | 2 |
929 | etiology-unknown | 1 |
930 | eucheuma | 1 |
931 | eusaprim | 1 |
932 | ex-usa | 1 |
933 | exapted | 1 |
934 | exemestene | 1 |
935 | exert* | 1 |
936 | f12.2 | 1 |
937 | fam22b | 1 |
938 | fed-pair | 1 |
939 | females/pen | 1 |
940 | fibringluraas | 1 |
941 | fitness* | 1 |
942 | flattering | 1 |
943 | flexknife | 1 |
944 | flubu | 1 |
945 | fluctin | 1 |
946 | fluctine | 1 |
947 | fluoropentyne | 1 |
948 | fluoxeren | 1 |
949 | flupirtin | 1 |
950 | flutter/pacemaker | 1 |
951 | fockian | 1 |
952 | follow* | 1 |
953 | fontex | 1 |
954 | foradile | 1 |
955 | fruitafit | 1 |
956 | fujianese | 1 |
957 | g1/g2-m | 1 |
958 | gal3st3 | 1 |
959 | gamma110 | 1 |
960 | gel/cream | 3 |
961 | gh7 | 1 |
962 | gingilone | 1 |
963 | ginsenol | 1 |
964 | ginsenoside* | 1 |
965 | glucocorticoid* | 1 |
966 | glycoprotein-receptoriib/iiia-antagonists | 1 |
967 | gmfad8-1/gmfad8-2 | 1 |
968 | gpqgiagq | 1 |
969 | gr.iii | 1 |
970 | greater-than-or-equal12 | 1 |
971 | gus-hsf | 1 |
972 | gym* | 2 |
973 | h-clinic | 1 |
974 | h2/n1co | 1 |
975 | hams40 | 1 |
976 | hbv-as02 | 1 |
977 | hct-trab | 1 |
978 | head-braces | 3 |
979 | hemoglobinsβ°-thalassemia | 1 |
980 | her2-inhibitors | 1 |
981 | herrings | 1 |
982 | high-treatment | 2 |
983 | history/findings | 1 |
984 | hmp50 | 1 |
985 | homoeopath* | 1 |
986 | hospitali* | 3 |
987 | hr80 | 1 |
988 | hydroa | 1 |
989 | hydrolystate | 1 |
990 | hydroxydeoxyguanosine | 1 |
991 | hyper-beta-lipoproteinemia | 1 |
992 | hyper-methylated | 1 |
993 | hyper-phosphatemia | 1 |
994 | hyperphenomena | 1 |
995 | hypersensation | 1 |
996 | i-dose | 1 |
997 | i.time | 1 |
998 | i46.1 | 1 |
999 | ic50=0.06 | 1 |
1000 | ic50~28.8 | 1 |
1001 | icn160 | 2 |
1002 | iff.drinking | 1 |
1003 | ifn-λ1 | 1 |
1004 | ihc2+/fluorescence | 1 |
1005 | iiia/m0 | 1 |
1006 | iiix3 | 1 |
1007 | il-1f11 | 1 |
1008 | immersion-chilled | 1 |
1009 | improvement=12·0 | 1 |
1010 | improvement=19·8 | 1 |
1011 | improvement=2·4 | 1 |
1012 | improvement=3·9 | 1 |
1013 | improvement=5·8 | 1 |
1014 | improvement=7·9 | 1 |
1015 | inhal* | 1 |
1016 | inogatran | 1 |
1017 | inpatient* | 3 |
1018 | insulin±metformin | 1 |
1019 | inter-clonal | 1 |
1020 | interferon-intolerant | 1 |
1021 | interleukin-2-activated | 1 |
1022 | intimidation/pressure | 1 |
1023 | iodoinsulin | 1 |
1024 | iop≥50 | 1 |
1025 | ipsv/cedv | 2 |
1026 | is5 | 1 |
1027 | isodicentric | 2 |
1028 | italy.1 | 1 |
1029 | ivus-measured | 1 |
1030 | jetamul-pleung-dang | 1 |
1031 | jmjd1a | 1 |
1032 | k-sensitive | 1 |
1033 | k117+k122 | 1 |
1034 | k2p9.1 | 1 |
1035 | kh3 | 1 |
1036 | kidney-failure | 1 |
1037 | kit-6 | 1 |
1038 | kugancao | 1 |
1039 | la-hs | 1 |
1040 | la-ls | 1 |
1041 | lactadherin | 3 |
1042 | lactoalbumin | 1 |
1043 | ladose | 1 |
1044 | lagoonal | 1 |
1045 | laryngofibroscopy | 1 |
1046 | ldhi—lower | 1 |
1047 | led-1,500 | 1 |
1048 | leningrad-zagreb | 1 |
1049 | leponex* | 1 |
1050 | light-therapy | 1 |
1051 | light/ae | 1 |
1052 | light/tu | 1 |
1053 | lighters | 3 |
1054 | lighting/ae | 1 |
1055 | linen* | 1 |
1056 | lip-licking | 1 |
1057 | lipidil | 1 |
1058 | lithane | 1 |
1059 | lithicarb | 1 |
1060 | lithobid | 1 |
1061 | ll5β | 2 |
1062 | loading→0.02 | 1 |
1063 | loading→0.04 | 1 |
1064 | locarbacef | 1 |
1065 | lomwe | 1 |
1066 | loofah | 1 |
1067 | lorien | 1 |
1068 | lovasta | 1 |
1069 | low-17 | 1 |
1070 | low-enthalpy | 1 |
1071 | low-tar/low-nicotine | 1 |
1072 | lumens/2.881 | 1 |
1073 | luminal/proximal | 1 |
1074 | luminex™ | 1 |
1075 | luteoliflavan | 1 |
1076 | lvef≥45 | 2 |
1077 | lynestrol | 1 |
1078 | m0,3 | 1 |
1079 | map≤65 | 1 |
1080 | maxaquine | 1 |
1081 | mbpp | 1 |
1082 | medopa | 1 |
1083 | mensibisib | 1 |
1084 | mepyramine | 1 |
1085 | metastase | 1 |
1086 | methyldiphenylphosphine | 1 |
1087 | metreurynter | 1 |
1088 | metylperon | 1 |
1089 | mfc=0.098 | 1 |
1090 | micamycin | 1 |
1091 | micro-injuries | 1 |
1092 | microerosions | 1 |
1093 | mic≥0.25 | 2 |
1094 | mid-to-low | 1 |
1095 | midsubstance | 1 |
1096 | minocycline-rifampin-impregnated | 1 |
1097 | mir-146a*g | 1 |
1098 | mivazerol | 3 |
1099 | mm/3 | 1 |
1100 | monthes | 1 |
1101 | months-12.8 | 2 |
1102 | months-80 | 1 |
1103 | motivat* | 1 |
1104 | moxibution | 2 |
1105 | moxicillin | 1 |
1106 | mph+ld | 1 |
1107 | muco-regulators | 1 |
1108 | muddled | 1 |
1109 | multi-skilling | 1 |
1110 | n-hexanol | 1 |
1111 | n-mers | 1 |
1112 | n-vacancies | 1 |
1113 | near-equivalent | 1 |
1114 | neoplasm* | 1 |
1115 | nevirapine+zidovudine/lamivudine | 1 |
1116 | nevirapine-nvp | 1 |
1117 | nicotine-administered | 1 |
1118 | nifedipine-atenolol | 1 |
1119 | nissen/gt | 1 |
1120 | nnips | 1 |
1121 | nocl | 1 |
1122 | non-attached | 1 |
1123 | non-citation | 1 |
1124 | non-communication | 1 |
1125 | non-complement | 1 |
1126 | non-hood | 1 |
1127 | non-linearities | 1 |
1128 | non-ordered | 1 |
1129 | non-professional* | 2 |
1130 | non-spacer | 1 |
1131 | non-swimming | 1 |
1132 | non-verterbal | 1 |
1133 | nonbad | 1 |
1134 | nonheparin-bonded | 1 |
1135 | not-prescribed-when-unwarranted | 1 |
1136 | not… | 1 |
1137 | novocain* | 1 |
1138 | np-a50-fs | 1 |
1139 | nsmri | 1 |
1140 | nstami | 1 |
1141 | ntagonists | 1 |
1142 | ntde | 1 |
1143 | nuelin | 1 |
1144 | o-cmeth-yl | 1 |
1145 | o-hydroxylate | 1 |
1146 | o-mo | 1 |
1147 | o=0.098 | 1 |
1148 | obese.we | 1 |
1149 | observe/investigate | 1 |
1150 | oculomotor-leads | 1 |
1151 | orthonovum | 1 |
1152 | other-therapies | 1 |
1153 | otherwise.to | 1 |
1154 | otherworld | 1 |
1155 | otogeneous | 1 |
1156 | over-elaboration | 1 |
1157 | overcompliance | 1 |
1158 | oxyethylene | 5 |
1159 | p.r272pfsx35 | 1 |
1160 | p.w147x | 1 |
1161 | p97 | 2 |
1162 | pain-induction/anger-induction | 1 |
1163 | panaxagin | 1 |
1164 | panaxoside* | 1 |
1165 | pandemrix® | 1 |
1166 | pansystole | 1 |
1167 | para-professional* | 1 |
1168 | partner-with-encouragement | 1 |
1169 | pd150606 | 1 |
1170 | peri-bronchovascular | 1 |
1171 | perpendic-ular | 2 |
1172 | peruik | 1 |
1173 | pgf2α=40.3 | 1 |
1174 | phosphonacetyl-l-aspartate | 1 |
1175 | physical* | 1 |
1176 | phytomed* | 1 |
1177 | pifithrin-µ | 1 |
1178 | pinacolone | 1 |
1179 | pinset | 1 |
1180 | placebo+opv | 1 |
1181 | placebo+reboxetine | 1 |
1182 | placebo-edoxaban | 1 |
1183 | placebo.treatment | 2 |
1184 | placebo/nwp06 | 1 |
1185 | pleur* | 1 |
1186 | pneumotachograph/flow-trigger | 1 |
1187 | polyantigen | 1 |
1188 | post-20 | 1 |
1189 | postbinding | 1 |
1190 | ppd4-5mm | 1 |
1191 | pp≥84 | 1 |
1192 | practi* | 1 |
1193 | pre-gaming | 1 |
1194 | pre/post-change | 1 |
1195 | precolored | 1 |
1196 | pregd | 1 |
1197 | prejugal | 1 |
1198 | prf/fat | 1 |
1199 | procain* | 1 |
1200 | procarbazine/lomustine/vincristine | 1 |
1201 | proced* | 4 |
1202 | progams | 1 |
1203 | propanolamines | 1 |
1204 | prosympathetic | 1 |
1205 | protein-55 | 1 |
1206 | protocolized-care | 1 |
1207 | protopanaxa* | 1 |
1208 | prozyn | 1 |
1209 | pseudo-cluster | 1 |
1210 | pt4pn0 | 1 |
1211 | q-banded | 1 |
1212 | qam-tid | 1 |
1213 | quenchability | 1 |
1214 | quilonum | 1 |
1215 | quinolin-6-yl | 1 |
1216 | r96.1 | 1 |
1217 | radiologist/resident | 1 |
1218 | rate-place | 1 |
1219 | ratio-or+/-95 | 1 |
1220 | re-registration | 1 |
1221 | reduce* | 1 |
1222 | reduct* | 1 |
1223 | reduction=25 | 1 |
1224 | refer* | 1 |
1225 | reflection/scattering | 1 |
1226 | regional/teaching | 1 |
1227 | rehabilitat* | 1 |
1228 | relapse* | 1 |
1229 | relational/indirect | 1 |
1230 | reliseal | 1 |
1231 | reneuron | 1 |
1232 | restroom | 1 |
1233 | reviews:1 | 1 |
1234 | rhabdmyolysis | 2 |
1235 | rice/d | 1 |
1236 | risperdal* | 1 |
1237 | rr=2.4 | 1 |
1238 | rs-infection | 1 |
1239 | ryu-ha | 1 |
1240 | s-trans-ch2chċo | 2 |
1241 | s526a | 1 |
1242 | saccarides | 1 |
1243 | saline/ondansetron | 1 |
1244 | sanzur | 1 |
1245 | sb0thal | 1 |
1246 | sbp⩾160 | 1 |
1247 | schinseng | 1 |
1248 | scooting | 1 |
1249 | self-manag* | 3 |
1250 | self-mutilations | 1 |
1251 | sem/wdx | 1 |
1252 | seroquel* | 1 |
1253 | session* | 1 |
1254 | sf-il-1ra | 1 |
1255 | sf-il-1β | 2 |
1256 | sf2/asf | 7 |
1257 | sga-c | 1 |
1258 | sh:10 | 1 |
1259 | sh:20 | 1 |
1260 | shinseng | 1 |
1261 | short-message-service | 1 |
1262 | signif- | 1 |
1263 | simvastatin-equivalent | 1 |
1264 | single-inhibitor | 1 |
1265 | sirna-akt | 1 |
1266 | slc4a2 | 1 |
1267 | smu-b | 1 |
1268 | snap-back | 1 |
1269 | snd1t5 | 1 |
1270 | snowy | 1 |
1271 | spd489 | 1 |
1272 | specularity | 1 |
1273 | spermatocele | 3 |
1274 | spiroplatin | 1 |
1275 | spp100 | 2 |
1276 | sprays/100 | 1 |
1277 | squamipedia | 1 |
1278 | ssris-appear | 1 |
1279 | ssz+hcq | 6 |
1280 | stablilized | 1 |
1281 | stammers | 1 |
1282 | state-effects | 1 |
1283 | steam-cooked | 1 |
1284 | stepping-up | 1 |
1285 | sterol/day | 1 |
1286 | stop*.alois | 1 |
1287 | stored-filtered | 1 |
1288 | subfascially/subcutaneously | 1 |
1289 | sur2 | 1 |
1290 | sur2b | 1 |
1291 | syringetin | 1 |
1292 | sβ0thal | 2 |
1293 | t6-t7 | 1 |
1294 | tang-min-ling-wan | 1 |
1295 | tanse-tansy | 1 |
1296 | taper* | 1 |
1297 | taper-down | 1 |
1298 | tarandus | 1 |
1299 | tbc-exposed | 2 |
1300 | tbi+bmc | 1 |
1301 | tech* | 4 |
1302 | tetavax® | 1 |
1303 | theotrim | 1 |
1304 | tim-3tg→tim-3tg | 1 |
1305 | tim-3tg→wt | 1 |
1306 | tinaquant | 1 |
1307 | tiotropium/salmeterol | 1 |
1308 | tm-mode | 1 |
1309 | tnf-blocker-resistant | 2 |
1310 | to-be-stopped | 1 |
1311 | tonsil* | 1 |
1312 | top-rope | 2 |
1313 | torasemide-ir | 1 |
1314 | toxicogenicity | 1 |
1315 | traffickers | 1 |
1316 | tranquil* | 1 |
1317 | trans-12 | 1 |
1318 | treatments-0.1 | 1 |
1319 | tria | 1 |
1320 | trial* | 1 |
1321 | trial-2.2 | 1 |
1322 | trial-8 | 1 |
1323 | triazol | 1 |
1324 | trihydroxylation | 2 |
1325 | tritonx-100 | 1 |
1326 | trofibial | 1 |
1327 | trychomes | 1 |
1328 | tselutin | 1 |
1329 | tsn-injection | 1 |
1330 | two-serving | 1 |
1331 | tyr-94 | 1 |
1332 | unformatted | 1 |
1333 | unpoled | 1 |
1334 | unproportional | 1 |
1335 | uroseptics | 1 |
1336 | v0=3.7 | 1 |
1337 | vasodepression | 1 |
1338 | veip | 1 |
1339 | venvanse | 1 |
1340 | vindesine-etoposide | 1 |
1341 | vitacel* | 1 |
1342 | vitagel | 1 |
1343 | volunt* | 1 |
1344 | water-vapour* | 1 |
1345 | wernicke* | 1 |
1346 | withdraw* | 1 |
1347 | wmd=-100.82 | 1 |
1348 | y321f | 1 |
1349 | years-9.99 | 1 |
1350 | yào | 4 |
1351 | zadaxin | 1 |
1352 | zalain | 1 |
1353 | zeldox* | 1 |
1354 | zerit | 1 |
1355 | zygaena | 1 |
1356 | zyprexa* | 1 |
1357 | |q| | 2 |
1358 | ~0.03 | 1 |
1359 | ~1.9 | 2 |
1360 | ~46-55 | 1 |
1361 | ~80-90 | 1 |
1362 | ~9160 | 1 |
1363 | £640,000 | 1 |
1364 | £70 | 1 |
1365 | ¹¹c-gsk189254 | 1 |
1366 | »7 | 1 |
1367 | ¿slc12a3¿ | 1 |
1368 | ×qrs | 1 |
1369 | α-d-glcp | 1 |
1370 | β-flupenthixol | 1 |
1371 | γ-ketoenals | 1 |
1372 | γ-methyl | 1 |
1373 | ε-amino | 1 |
1374 | θ-zrp | 1 |
1375 | ‘dash | 1 |
1376 | €321 | 1 |
1377 | ∆smds | 1 |
1378 | ∼1,600 | 1 |
1379 | ∼1100 | 2 |
1380 | ∼17.4 | 1 |
1381 | ∼3.72-3.77 | 1 |
1382 | ≤-1.63 | 1 |
1383 | ≤0.10 | 1 |
1384 | ≤0.73 | 1 |
1385 | ≤1.95 | 1 |
1386 | ≤125/75 | 2 |
1387 | ≤13.9 | 1 |
1388 | ≤15.5 | 1 |
1389 | ≤2.6 | 3 |
1390 | ≤3.1 | 1 |
1391 | ≤46 | 2 |
1392 | ≤700 | 1 |
1393 | ≥0.11 | 1 |
1394 | ≥10/15 | 1 |
1395 | ≥110/65 | 1 |
1396 | ≥110/70 | 2 |
1397 | ≥125/75 | 1 |
1398 | ≥130/75 | 1 |
1399 | ≥140/85 | 2 |
1400 | ≥160/90 | 1 |
1401 | ≥180/95 | 1 |
1402 | ≥1·7 | 1 |
1403 | ≥2.7 | 4 |
1404 | ≥200-350 | 1 |
1405 | ≥27 | 16 |
1406 | ≥300mg/24h | 1 |
1407 | ≥540 | 1 |
1408 | ≥56.5 | 1 |
1409 | ≥6/9 | 1 |
1410 | ≥7·8 | 1 |
1411 | ⩽3.0 | 1 |
1412 | ⩽30 | 1 |
1413 | ⩾140 | 1 |
1414 | ⩾210 | 1 |
1415 | ⩾80 | 2 |
1416 | 10 | 4 |
1 | protopanaxa* | 1 |
2 | zyprexa* | 1 |
3 | antimicrob* | 4 |
4 | danc* | 2 |
5 | adenocarc* | 1 |
6 | bed* | 1 |
7 | proced* | 4 |
8 | phytomed* | 1 |
9 | glucocorticoid* | 1 |
10 | corticosteroid* | 2 |
11 | reduce* | 1 |
12 | ginsenoside* | 1 |
13 | panaxoside* | 1 |
14 | wernicke* | 1 |
15 | cycle* | 1 |
16 | adhere* | 2 |
17 | relapse* | 1 |
18 | self-manag* | 3 |
19 | tech* | 4 |
20 | homoeopath* | 1 |
21 | hospitali* | 3 |
22 | practi* | 1 |
23 | drink* | 2 |
24 | disk* | 1 |
25 | physical* | 1 |
26 | risperdal* | 1 |
27 | inhal* | 1 |
28 | trial* | 1 |
29 | para-professional* | 1 |
30 | non-professional* | 2 |
31 | aslavital* | 1 |
32 | vitacel* | 1 |
33 | seroquel* | 1 |
34 | tonsil* | 1 |
35 | tranquil* | 1 |
36 | carcinom* | 1 |
37 | neoplasm* | 1 |
38 | gym* | 2 |
39 | dysthym* | 1 |
40 | linen* | 1 |
41 | procain* | 1 |
42 | novocain* | 1 |
43 | aneurin* | 1 |
44 | session* | 1 |
45 | admission* | 4 |
46 | acup* | 1 |
47 | refer* | 1 |
48 | taper* | 1 |
49 | endur* | 1 |
50 | pleur* | 1 |
51 | water-vapour* | 1 |
52 | fitness* | 1 |
53 | cessat* | 1 |
54 | rehabilitat* | 1 |
55 | motivat* | 1 |
56 | reduct* | 1 |
57 | arthrit* | 1 |
58 | inpatient* | 3 |
59 | convent* | 2 |
60 | volunt* | 1 |
61 | exert* | 1 |
62 | dropout* | 2 |
63 | activ* | 1 |
64 | withdraw* | 1 |
65 | follow* | 1 |
66 | leponex* | 1 |
67 | zeldox* | 1 |
68 | anxioly* | 1 |
69 | 4/+4/+ | 1 |
70 | =2+ | 4 |
71 | 0.5+ | 1 |
72 | cd4-cd8+ | 2 |
73 | er-her2- | 1 |
74 | =3- | 1 |
75 | disulfide- | 1 |
76 | econazole- | 1 |
77 | signif- | 1 |
78 | clomi- | 1 |
79 | -18-antibody- | 1 |
80 | 0.25mg/ | 1 |
81 | =30.0 | 1 |
82 | =40.0 | 1 |
83 | 0.02-1.0 | 1 |
84 | =-1.0 | 2 |
85 | =1.0 | 14 |
86 | =12.0 | 2 |
87 | =2.0 | 21 |
88 | 30.0+/-3.0 | 1 |
89 | =73.0 | 1 |
90 | =3.0 | 15 |
91 | 18.9±3.0 | 1 |
92 | ⩽3.0 | 1 |
93 | 132.3/74.0 | 1 |
94 | =4.0 | 11 |
95 | 48.0±4.0 | 1 |
96 | 7.8-15.0 | 1 |
97 | =65.0 | 2 |
98 | =75.0 | 1 |
99 | =26.0 | 1 |
100 | =6.0 | 6 |
101 | =7.0 | 6 |
102 | 20.3-17.6-28.0 | 1 |
103 | =38.0 | 1 |
104 | 16.2-58.0 | 1 |
105 | =98.0 | 1 |
106 | =8.0 | 2 |
107 | 50±8.0 | 1 |
108 | -30.1/-19.0 | 1 |
109 | =29.0 | 1 |
110 | =9.0 | 3 |
111 | 0.20-2.00 | 1 |
112 | 375.00 | 1 |
113 | =100,000 | 6 |
114 | 200,000-600,000 | 1 |
115 | =10,000 | 5 |
116 | £640,000 | 1 |
117 | =2,000 | 1 |
118 | =3,000 | 2 |
119 | =15,000 | 2 |
120 | =2000 | 1 |
121 | =5000 | 4 |
122 | 820-8000 | 1 |
123 | tritonx-100 | 1 |
124 | 0.010-0.100 | 1 |
125 | =140/100 | 2 |
126 | =160/100 | 3 |
127 | sprays/100 | 1 |
128 | ∼1100 | 2 |
129 | =100 | 58 |
130 | ages-mf100 | 1 |
131 | spp100 | 2 |
132 | =20/200 | 2 |
133 | =200 | 29 |
134 | 0.5-300 | 1 |
135 | 7.300 | 1 |
136 | =300 | 12 |
137 | =5400 | 1 |
138 | =400 | 12 |
139 | led-1,500 | 1 |
140 | 480-500 | 1 |
141 | =1500 | 1 |
142 | =500 | 15 |
143 | ∼1,600 | 1 |
144 | 22600 | 1 |
145 | =600 | 3 |
146 | 25-700 | 1 |
147 | =700 | 3 |
148 | ≤700 | 1 |
149 | =800 | 6 |
150 | 3.0-10 | 1 |
151 | ≤0.10 | 1 |
152 | =5/10 | 2 |
153 | =180/110 | 1 |
154 | =110 | 16 |
155 | gamma110 | 1 |
156 | 142-210 | 1 |
157 | =210 | 1 |
158 | ⩾210 | 1 |
159 | 36.310 | 1 |
160 | sh:10 | 1 |
161 | =10 | 158 |
162 | c14h10 | 1 |
163 | 10 | 4 |
164 | =10-20 | 2 |
165 | post-20 | 1 |
166 | =1.20 | 2 |
167 | =4.20 | 2 |
168 | =6.20 | 1 |
169 | 35/20 | 1 |
170 | =120 | 19 |
171 | =220 | 5 |
172 | 1.0320 | 1 |
173 | 6,920 | 1 |
174 | sh:20 | 1 |
175 | =20 | 88 |
176 | =5.30 | 1 |
177 | =130 | 28 |
178 | arg130 | 2 |
179 | -230 | 2 |
180 | 28,3330 | 1 |
181 | 9,530 | 1 |
182 | =30 | 138 |
183 | d≥30 | 1 |
184 | ⩽30 | 1 |
185 | 0.35-0.40 | 2 |
186 | =0.40 | 23 |
187 | =1.40 | 7 |
188 | =20/40 | 4 |
189 | =1140 | 1 |
190 | =140 | 51 |
191 | ⩾140 | 1 |
192 | =240 | 8 |
193 | =340 | 1 |
194 | =2440 | 1 |
195 | ≥540 | 1 |
196 | =940 | 1 |
197 | =40 | 135 |
198 | hams40 | 1 |
199 | 65±40 | 1 |
200 | 400-50 | 1 |
201 | 0.28-0.50 | 1 |
202 | =1.50 | 2 |
203 | =3.75-6.50 | 1 |
204 | =20/50 | 1 |
205 | 97/50 | 1 |
206 | 51-150 | 1 |
207 | 0.16-150 | 1 |
208 | =150 | 23 |
209 | 40-250 | 1 |
210 | 25/250 | 1 |
211 | =250 | 10 |
212 | ≥200-350 | 1 |
213 | =350 | 7 |
214 | 350-650 | 1 |
215 | 570-850 | 1 |
216 | hmp50 | 1 |
217 | iop≥50 | 1 |
218 | dddr-60 | 1 |
219 | =1.60 | 1 |
220 | =2.60 | 3 |
221 | =4.60 | 1 |
222 | 11.20-55.60 | 1 |
223 | =3/60 | 1 |
224 | 3.060 | 1 |
225 | ~9160 | 1 |
226 | =160 | 29 |
227 | icn160 | 2 |
228 | sbp⩾160 | 1 |
229 | =260 | 1 |
230 | =460 | 1 |
231 | 0.04-2.560 | 1 |
232 | 2.960 | 1 |
233 | =60 | 115 |
234 | 3.37-5.70 | 1 |
235 | 39.70 | 1 |
236 | ≥110/70 | 2 |
237 | 8,070 | 1 |
238 | 160-170 | 1 |
239 | =170 | 2 |
240 | 18/370 | 1 |
241 | 16.470 | 1 |
242 | =70 | 94 |
243 | £70 | 1 |
244 | 130-140/70-80 | 1 |
245 | 2.2-80 | 1 |
246 | months-80 | 1 |
247 | =130/80 | 2 |
248 | 105/80 | 1 |
249 | =20,180 | 1 |
250 | 31-180 | 1 |
251 | 5180 | 1 |
252 | =180 | 8 |
253 | 2.280 | 1 |
254 | =280 | 1 |
255 | =480 | 1 |
256 | at1g35580 | 1 |
257 | 17,980 | 1 |
258 | =80 | 60 |
259 | hr80 | 1 |
260 | ⩾80 | 2 |
261 | ~80-90 | 1 |
262 | =27.90 | 1 |
263 | =140/90 | 13 |
264 | =160/90 | 4 |
265 | ≥160/90 | 1 |
266 | =190 | 7 |
267 | =90 | 55 |
268 | ci90 | 1 |
269 | dbp≥90 | 1 |
270 | iiia/m0 | 1 |
271 | pt4pn0 | 1 |
272 | improvement=12·0 | 1 |
273 | treatments-0.1 | 1 |
274 | =100.1 | 2 |
275 | -11.1±10.1 | 1 |
276 | -14.2±20.1 | 1 |
277 | -10.9±20.1 | 1 |
278 | 41.1-70.1 | 1 |
279 | =0.1 | 21 |
280 | 10-11.1 | 2 |
281 | =11.1 | 4 |
282 | =1.1 | 6 |
283 | 9.5±1.1 | 1 |
284 | ≤3.1 | 1 |
285 | =1.9-4.1 | 1 |
286 | =14.1 | 1 |
287 | age=54.1 | 1 |
288 | 43.3±4.1 | 1 |
289 | =106.1 | 1 |
290 | =36.1 | 2 |
291 | i46.1 | 1 |
292 | r96.1 | 1 |
293 | =77.1 | 1 |
294 | 11.0/8.1 | 1 |
295 | =38.1 | 1 |
296 | 150.6/99.1 | 1 |
297 | k2p9.1 | 1 |
298 | italy.1 | 1 |
299 | 5.76/1 | 1 |
300 | 167/101 | 1 |
301 | =101 | 2 |
302 | =5,701 | 1 |
303 | 4.801 | 1 |
304 | 109+/-11 | 1 |
305 | 7.1-11 | 1 |
306 | =1.1+/-0.11 | 1 |
307 | ≥0.11 | 1 |
308 | 64.12±0.11 | 1 |
309 | -23.11 | 2 |
310 | 33/11 | 1 |
311 | =111 | 2 |
312 | 13.711 | 1 |
313 | =11 | 17 |
314 | il-1f11 | 1 |
315 | 154±11 | 1 |
316 | 5·11 | 2 |
317 | 2.41-5.21 | 1 |
318 | =6.21 | 1 |
319 | =221 | 1 |
320 | €321 | 1 |
321 | =21 | 20 |
322 | 22.28±7.31 | 1 |
323 | 38,631 | 1 |
324 | =31 | 7 |
325 | /f/kg=4.441 | 1 |
326 | =41 | 9 |
327 | 5.23±0.51 | 1 |
328 | and-1051 | 1 |
329 | =51 | 5 |
330 | dk007571 | 1 |
331 | =6,971 | 1 |
332 | =71 | 3 |
333 | 76-81 | 1 |
334 | 73.29±0.81 | 1 |
335 | 7.62±1.81 | 1 |
336 | 142/81 | 1 |
337 | =0.481 | 1 |
338 | =2581 | 1 |
339 | lumens/2.881 | 1 |
340 | =81 | 2 |
341 | 398.91 | 1 |
342 | =91 | 4 |
343 | reviews:1 | 1 |
344 | =1 | 196 |
345 | enox1 | 1 |
346 | +1·1 | 1 |
347 | ifn-λ1 | 1 |
348 | cyp2d6*2 | 1 |
349 | =0.06-2 | 1 |
350 | gmfad8-1/gmfad8-2 | 1 |
351 | elfra-2 | 1 |
352 | acetonitrile-2 | 1 |
353 | 35.6+/-10.2 | 1 |
354 | 63.9+/-10.2 | 1 |
355 | =0.2 | 14 |
356 | 1.95-21.2 | 1 |
357 | =1.2 | 13 |
358 | 3.5±1.2 | 1 |
359 | -0.7±2.1/-1.6±1.2 | 1 |
360 | trial-2.2 | 1 |
361 | f12.2 | 1 |
362 | -18.1±12.2 | 1 |
363 | -11.3±12.2 | 1 |
364 | =32.2 | 1 |
365 | 252.2 | 1 |
366 | =162.2 | 1 |
367 | =2.2 | 8 |
368 | 92.8/63.2 | 1 |
369 | =3.2 | 5 |
370 | 31.9-34.2 | 1 |
371 | 50.6±34.2 | 1 |
372 | age=21.9±4.2 | 1 |
373 | =25.2 | 3 |
374 | =5.2 | 6 |
375 | =6.2 | 6 |
376 | =18.2 | 2 |
377 | -138.2 | 1 |
378 | -20.3±19.2 | 1 |
379 | loading→0.02 | 1 |
380 | hbv-as02 | 1 |
381 | 31+/-12 | 1 |
382 | trans-12 | 1 |
383 | =112 | 1 |
384 | 7.612 | 1 |
385 | =12 | 64 |
386 | greater-than-or-equal12 | 1 |
387 | =44±12 | 1 |
388 | 138±12 | 1 |
389 | 2ν12 | 1 |
390 | 3.76-15.22 | 1 |
391 | 7,122 | 1 |
392 | =122 | 1 |
393 | k117+k122 | 1 |
394 | =22 | 11 |
395 | =132 | 3 |
396 | =32 | 15 |
397 | d≥32 | 1 |
398 | 80-42 | 1 |
399 | 2.642 | 1 |
400 | =42 | 3 |
401 | =4.52 | 1 |
402 | =149.52 | 1 |
403 | 107/52 | 1 |
404 | =1,452 | 1 |
405 | =52 | 9 |
406 | blood-62 | 1 |
407 | 30.62 | 2 |
408 | 138.62 | 1 |
409 | =162 | 1 |
410 | -4,072 | 1 |
411 | =172 | 1 |
412 | =72 | 18 |
413 | wmd=-100.82 | 1 |
414 | =82 | 4 |
415 | 52-92 | 1 |
416 | =592 | 1 |
417 | =792 | 1 |
418 | 0·992 | 1 |
419 | =2 | 190 |
420 | slc4a2 | 1 |
421 | =cin2 | 5 |
422 | sur2 | 1 |
423 | 25×2×2 | 2 |
424 | =0·2 | 1 |
425 | m0,3 | 1 |
426 | =-3 | 3 |
427 | -18:3n-3 | 2 |
428 | 42.6+/-0.3 | 1 |
429 | pgf2α=40.3 | 1 |
430 | 13.8-80.3 | 1 |
431 | 290.3 | 1 |
432 | =0.3 | 9 |
433 | =11.3 | 2 |
434 | =1.3 | 8 |
435 | =3.3 | 2 |
436 | 39.9+/-4.3 | 1 |
437 | 172.3/104.3 | 1 |
438 | 37.8-64.3 | 1 |
439 | 171.0/94.3 | 1 |
440 | =25.3 | 1 |
441 | -32.4±8.3 | 1 |
442 | =1/3 | 2 |
443 | mm/3 | 1 |
444 | 1,03 | 1 |
445 | ~0.03 | 1 |
446 | -13.03 | 1 |
447 | =103 | 1 |
448 | 29-113 | 1 |
449 | arg-113 | 1 |
450 | =13 | 20 |
451 | =2023 | 1 |
452 | =123 | 2 |
453 | =23 | 10 |
454 | =3.33 | 1 |
455 | 66gy/33 | 1 |
456 | 1/133 | 1 |
457 | =133 | 2 |
458 | =33 | 16 |
459 | 53.43 | 1 |
460 | =1143 | 1 |
461 | =343 | 1 |
462 | =443 | 1 |
463 | =843 | 1 |
464 | =43 | 3 |
465 | =653 | 1 |
466 | 2.10±0.63 | 1 |
467 | ≤-1.63 | 1 |
468 | =163 | 4 |
469 | ≤0.73 | 1 |
470 | =8773 | 1 |
471 | =73 | 5 |
472 | =183 | 2 |
473 | 156.93 | 1 |
474 | =493 | 1 |
475 | =3 | 185 |
476 | aldh1a3 | 1 |
477 | kh3 | 1 |
478 | =gi3 | 1 |
479 | cn3 | 1 |
480 | =cin3 | 8 |
481 | =t3 | 1 |
482 | gal3st3 | 1 |
483 | 10x10x3 | 1 |
484 | =x3 | 1 |
485 | iiix3 | 1 |
486 | 8.8±3 | 1 |
487 | 2.6-4 | 1 |
488 | /+0.4 | 1 |
489 | =0.4 | 3 |
490 | =1.4 | 8 |
491 | rr=2.4 | 1 |
492 | 13.4±2.4 | 1 |
493 | 10-13.4 | 1 |
494 | =3.4 | 3 |
495 | =66.4 | 1 |
496 | ∼17.4 | 1 |
497 | =7.4 | 2 |
498 | =19.4 | 2 |
499 | =2/4 | 1 |
500 | loading→0.04 | 1 |
501 | 71.04 | 2 |
502 | -23.14 | 1 |
503 | =4.14 | 2 |
504 | 115.14 | 1 |
505 | :0.0014 | 1 |
506 | =2114 | 1 |
507 | =14 | 22 |
508 | 10.46+/-1.24 | 1 |
509 | =6.24 | 1 |
510 | =1024 | 1 |
511 | =124 | 1 |
512 | =24 | 20 |
513 | =134 | 2 |
514 | =34 | 11 |
515 | =144 | 3 |
516 | =244 | 1 |
517 | =344 | 1 |
518 | =444 | 1 |
519 | =44 | 6 |
520 | =154 | 1 |
521 | -90±154 | 1 |
522 | ¹¹c-gsk189254 | 1 |
523 | =54 | 4 |
524 | 25.5-64 | 1 |
525 | 86.64 | 1 |
526 | =164 | 1 |
527 | =64 | 8 |
528 | 34.74 | 2 |
529 | =74 | 4 |
530 | =138/84 | 1 |
531 | =84 | 5 |
532 | pp≥84 | 1 |
533 | tyr-94 | 1 |
534 | 6.194 | 1 |
535 | =94 | 2 |
536 | =4 | 96 |
537 | cd3/cd4 | 1 |
538 | cyclic-po4 | 1 |
539 | improvement=2·4 | 1 |
540 | 38·4-89·4 | 1 |
541 | 8-5 | 4 |
542 | =10.5 | 3 |
543 | =0.5 | 21 |
544 | -2.1/-1.5 | 1 |
545 | age=58.1+/-11.5 | 1 |
546 | =1.5 | 25 |
547 | 42.7±1.5 | 1 |
548 | =-2.5 | 7 |
549 | 90-112.5 | 1 |
550 | =12.5 | 5 |
551 | =32.5 | 1 |
552 | =62.5 | 2 |
553 | =2.5 | 18 |
554 | =-23.5 | 1 |
555 | 30.1-33.5 | 1 |
556 | =3.5 | 11 |
557 | =4.5 | 10 |
558 | =-5.5 | 1 |
559 | ≤15.5 | 1 |
560 | 20.7±25.5 | 1 |
561 | =5.5 | 10 |
562 | 23±5.5 | 1 |
563 | =16.5 | 1 |
564 | =26.5 | 2 |
565 | ≥56.5 | 1 |
566 | =6.5 | 12 |
567 | =17.5 | 2 |
568 | =27.5 | 2 |
569 | =7.5 | 7 |
570 | difference=7.5 | 1 |
571 | 11.2/8.5 | 1 |
572 | 13.2/8.5 | 1 |
573 | =98.5 | 1 |
574 | 62.8±8.5 | 1 |
575 | =39.5 | 1 |
576 | 63.63±10.05 | 1 |
577 | 69.05 | 2 |
578 | =105 | 8 |
579 | 21,505 | 1 |
580 | 5.1-15 | 1 |
581 | 0.14-0.15 | 1 |
582 | ≥10/15 | 1 |
583 | 84-115 | 1 |
584 | =115 | 3 |
585 | 4.715 | 1 |
586 | =15 | 64 |
587 | 4.13-25 | 1 |
588 | mic≥0.25 | 2 |
589 | =125 | 4 |
590 | =925 | 1 |
591 | =25 | 69 |
592 | reduction=25 | 1 |
593 | 20–25 | 1 |
594 | /0.35 | 1 |
595 | =135 | 5 |
596 | 25,335 | 1 |
597 | =35 | 69 |
598 | p.r272pfsx35 | 1 |
599 | 138±35 | 2 |
600 | =145 | 5 |
601 | =245 | 1 |
602 | =45 | 63 |
603 | lvef≥45 | 2 |
604 | ~46-55 | 1 |
605 | protein-55 | 1 |
606 | 98/55 | 1 |
607 | =155 | 2 |
608 | 8.455 | 1 |
609 | =855 | 1 |
610 | =55 | 34 |
611 | ≥110/65 | 1 |
612 | ,165 | 1 |
613 | =65 | 128 |
614 | map≤65 | 1 |
615 | 13.92±2.75 | 1 |
616 | ≥130/75 | 1 |
617 | =115/75 | 1 |
618 | ≤125/75 | 2 |
619 | ≥125/75 | 1 |
620 | 3.075 | 1 |
621 | =175 | 4 |
622 | 2.475 | 1 |
623 | =75 | 45 |
624 | =-5.85 | 1 |
625 | =130/85 | 1 |
626 | ≥140/85 | 2 |
627 | =135/85 | 1 |
628 | bnp≥285 | 1 |
629 | =85 | 27 |
630 | 0.12,95 | 1 |
631 | 1.04,95 | 1 |
632 | 2.24,95 | 1 |
633 | 0.88,95 | 1 |
634 | ratio-or+/-95 | 1 |
635 | 43-95 | 1 |
636 | ≤1.95 | 1 |
637 | ≥180/95 | 1 |
638 | 165/95 | 1 |
639 | 0.33:95 | 1 |
640 | =95 | 10 |
641 | =5 | 122 |
642 | is5 | 1 |
643 | snd1t5 | 1 |
644 | 25·5 | 2 |
645 | kit-6 | 1 |
646 | 38.9=10.6 | 1 |
647 | 65.0+/-20.6 | 1 |
648 | 8.9-40.6 | 1 |
649 | =2.6 | 5 |
650 | ≤2.6 | 3 |
651 | 91.8/73.6 | 1 |
652 | 6.0/5.6 | 1 |
653 | =5.6 | 9 |
654 | =96.6 | 1 |
655 | 27.1±7.6 | 1 |
656 | 1.6±8.6 | 1 |
657 | 7.32-70.06 | 1 |
658 | ic50=0.06 | 1 |
659 | -21.06 | 1 |
660 | =106 | 1 |
661 | pd150606 | 1 |
662 | placebo/nwp06 | 1 |
663 | 25/116 | 1 |
664 | 175/116 | 1 |
665 | =116 | 1 |
666 | 8.416 | 1 |
667 | =16 | 36 |
668 | arg16-gly16 | 1 |
669 | 8·16 | 2 |
670 | 2.1/0.1/0.26 | 1 |
671 | =3.26 | 1 |
672 | =126 | 5 |
673 | 83.426 | 1 |
674 | =26 | 15 |
675 | =3.36 | 2 |
676 | =5.36 | 1 |
677 | 5.136 | 1 |
678 | =236 | 1 |
679 | =36 | 14 |
680 | 216.46 | 1 |
681 | 99.46 | 1 |
682 | ≤46 | 2 |
683 | =56 | 7 |
684 | =4.66 | 1 |
685 | 35/366 | 1 |
686 | =566 | 1 |
687 | +rt=66 | 1 |
688 | =7.76 | 1 |
689 | -9.76 | 2 |
690 | 4776 | 2 |
691 | =76 | 6 |
692 | =-0.86 | 1 |
693 | 1.88/0.86 | 1 |
694 | 0.96-1.86 | 1 |
695 | -1,186 | 1 |
696 | 128±86 | 1 |
697 | 1.57±0.96 | 1 |
698 | =196 | 1 |
699 | :0.596 | 1 |
700 | 138.896 | 1 |
701 | =96 | 6 |
702 | 1:6:6 | 1 |
703 | =6 | 83 |
704 | 5.1-7 | 1 |
705 | 4.6+/-1.7 | 1 |
706 | =1.7 | 5 |
707 | -16±1.7 | 1 |
708 | =2.7 | 4 |
709 | ≥2.7 | 4 |
710 | =25.5±2.7 | 1 |
711 | =73.7 | 1 |
712 | v0=3.7 | 1 |
713 | /5.7 | 1 |
714 | 12.9/7.7 | 1 |
715 | =39.9±17.7 | 1 |
716 | -14.1/-8.7 | 1 |
717 | 106/5.9-48.7 | 1 |
718 | =8.7 | 2 |
719 | -8.4±8.7 | 1 |
720 | -16±8.7 | 1 |
721 | 89.03±1.07 | 1 |
722 | 2.41-3.07 | 1 |
723 | 77.07 | 2 |
724 | =107 | 2 |
725 | =1207 | 1 |
726 | low-17 | 1 |
727 | =2.17 | 1 |
728 | =4.17 | 2 |
729 | =5.17 | 2 |
730 | =117 | 3 |
731 | 5.917 | 1 |
732 | =17 | 14 |
733 | ctx-m-27 | 1 |
734 | 0.32±0.027 | 1 |
735 | 16.627 | 1 |
736 | =26,927 | 1 |
737 | =27 | 9 |
738 | ≥27 | 16 |
739 | 108+/-37 | 1 |
740 | =237 | 1 |
741 | =1,337 | 1 |
742 | =37 | 15 |
743 | =147 | 1 |
744 | 177-247 | 1 |
745 | 33,547 | 1 |
746 | =47 | 10 |
747 | =0.157 | 1 |
748 | =57 | 6 |
749 | -0.2±57 | 1 |
750 | 3.48+/-0.67 | 1 |
751 | =2.67 | 2 |
752 | =267 | 1 |
753 | =67 | 11 |
754 | ∼3.72-3.77 | 1 |
755 | 130/77 | 1 |
756 | 2.67±0.87 | 1 |
757 | =18.87 | 1 |
758 | =87 | 3 |
759 | =134.97 | 1 |
760 | 9097 | 1 |
761 | =1397 | 1 |
762 | =397 | 1 |
763 | =97 | 4 |
764 | p97 | 2 |
765 | =7 | 98 |
766 | gh7 | 1 |
767 | t6-t7 | 1 |
768 | ≥1·7 | 1 |
769 | »7 | 1 |
770 | 75+/-8 | 2 |
771 | trial-8 | 1 |
772 | 19.5±11.8 | 1 |
773 | 431.8 | 1 |
774 | =1.8 | 5 |
775 | 23.5+/-2.8 | 1 |
776 | months-12.8 | 2 |
777 | -38.4±2.8 | 1 |
778 | 7.7±2.8 | 1 |
779 | 3.2-3.8 | 2 |
780 | /13.8 | 2 |
781 | 91.2-83.8 | 1 |
782 | 10.46±3.8 | 1 |
783 | =10.5±4.8 | 1 |
784 | =-6.8 | 1 |
785 | 35.2±6.8 | 1 |
786 | 13.3/7.8 | 1 |
787 | =37.8 | 1 |
788 | =7.8 | 7 |
789 | 56.2+/-8.8 | 1 |
790 | ic50~28.8 | 1 |
791 | =19.8 | 1 |
792 | -299.8 | 1 |
793 | =9.8 | 1 |
794 | 11.108 | 1 |
795 | 7+/-18 | 2 |
796 | 84.25±1.18 | 1 |
797 | =0.618 | 1 |
798 | =18 | 88 |
799 | :1.28 | 1 |
800 | 14.90±7.28 | 1 |
801 | =.28 | 1 |
802 | :0.028 | 1 |
803 | 5.128 | 1 |
804 | =28 | 13 |
805 | =-1.38 | 1 |
806 | -31.38 | 1 |
807 | 1.57-2.38 | 1 |
808 | =1038 | 1 |
809 | =138 | 1 |
810 | =38 | 13 |
811 | =0.20-0.48 | 1 |
812 | =148 | 1 |
813 | =48 | 18 |
814 | 66-58 | 1 |
815 | =158 | 1 |
816 | =658 | 1 |
817 | 1.968 | 1 |
818 | 131/78 | 1 |
819 | 2.378 | 1 |
820 | +0.0678 | 1 |
821 | 8,978 | 1 |
822 | =78 | 5 |
823 | =3.88 | 2 |
824 | 79.88 | 1 |
825 | =188 | 1 |
826 | chr-nc=388 | 1 |
827 | =88 | 3 |
828 | =-21.98 | 1 |
829 | =152/98 | 1 |
830 | mfc=0.098 | 1 |
831 | o=0.098 | 1 |
832 | =198 | 1 |
833 | =98 | 4 |
834 | =8 | 55 |
835 | 65·8 | 2 |
836 | improvement=5·8 | 1 |
837 | ≥7·8 | 1 |
838 | improvement=19·8 | 1 |
839 | =-9 | 2 |
840 | 440.9 | 1 |
841 | =0.9 | 12 |
842 | -2.9±0.9 | 1 |
843 | /-1.9 | 1 |
844 | =1.9 | 4 |
845 | ~1.9 | 2 |
846 | 7.0-13.9 | 1 |
847 | ≤13.9 | 1 |
848 | =63.9 | 1 |
849 | 4.7-4.9 | 1 |
850 | 9.3/4.9 | 1 |
851 | =24.9 | 2 |
852 | -10.3/-6.9 | 1 |
853 | age=62.4+/-8.9 | 1 |
854 | 4.8-18.9 | 1 |
855 | age=59.8+/-9.9 | 1 |
856 | 15-19.9 | 1 |
857 | 27-29.9 | 1 |
858 | 97-99.9 | 1 |
859 | ≥6/9 | 1 |
860 | =3.09 | 2 |
861 | =0.0009 | 1 |
862 | 151-159/100-109 | 2 |
863 | =109 | 2 |
864 | 86.19 | 1 |
865 | 3.119 | 1 |
866 | =119 | 3 |
867 | 312.0-319 | 1 |
868 | =19 | 11 |
869 | 996.29 | 1 |
870 | =29 | 12 |
871 | =639 | 1 |
872 | =39 | 8 |
873 | 35.6-49 | 1 |
874 | =149 | 1 |
875 | 160-749 | 1 |
876 | 135-159 | 1 |
877 | =159 | 1 |
878 | =359 | 1 |
879 | =5,759 | 2 |
880 | =59 | 4 |
881 | =69 | 10 |
882 | 24-79 | 1 |
883 | 3900/79 | 1 |
884 | 27/79 | 1 |
885 | =179 | 1 |
886 | 1.779 | 1 |
887 | 121-139/81-89 | 1 |
888 | spd489 | 1 |
889 | =89 | 4 |
890 | 85.9-99 | 1 |
891 | -.99 | 1 |
892 | 120.99 | 1 |
893 | years-9.99 | 1 |
894 | =199 | 1 |
895 | =1,699 | 1 |
896 | 300-799 | 1 |
897 | =99 | 1 |
898 | =9 | 24 |
899 | 8×9 | 2 |
900 | =-1·9 | 1 |
901 | improvement=3·9 | 1 |
902 | improvement=7·9 | 1 |
903 | -551a | 2 |
904 | jmjd1a | 1 |
905 | =3a | 1 |
906 | d254a | 1 |
907 | s526a | 1 |
908 | e138a | 1 |
909 | ryu-ha | 1 |
910 | squamipedia | 1 |
911 | hyper-beta-lipoproteinemia | 1 |
912 | hemoglobinsβ°-thalassemia | 1 |
913 | hyper-phosphatemia | 1 |
914 | clitoridectomia | 1 |
915 | bradyphrenia | 2 |
916 | tria | 1 |
917 | brush/spatula | 2 |
918 | -sma | 2 |
919 | eucheuma | 1 |
920 | zygaena | 1 |
921 | hyperphenomena | 1 |
922 | enoxaparina | 1 |
923 | hydroa | 1 |
924 | medopa | 1 |
925 | sf-il-1ra | 1 |
926 | akokobesa | 1 |
927 | ex-usa | 1 |
928 | lovasta | 1 |
929 | 'divya | 1 |
930 | smu-b | 1 |
931 | fam22b | 1 |
932 | sur2b | 1 |
933 | 35b | 1 |
934 | cdab | 1 |
935 | hct-trab | 1 |
936 | 5ht₃ab | 1 |
937 | leningrad-zagreb | 1 |
938 | cdg-ib | 1 |
939 | bsc+sunitinib | 1 |
940 | mensibisib | 1 |
941 | lithicarb | 1 |
942 | sga-c | 1 |
943 | h-clinic | 1 |
944 | barocaloric | 1 |
945 | isodicentric | 2 |
946 | prosympathetic | 1 |
947 | tbi+bmc | 1 |
948 | doc/pc | 1 |
949 | =37.5degreesc | 1 |
950 | =38degreesc | 1 |
951 | 1,575°c | 1 |
952 | 76.7°c | 1 |
953 | rice/d | 1 |
954 | =1mg/kg/d | 1 |
955 | 120mg/d | 1 |
956 | clec4d | 2 |
957 | nonbad | 1 |
958 | condition-induced | 1 |
959 | co-produced | 2 |
960 | q-banded | 1 |
961 | nonheparin-bonded | 1 |
962 | air-packaged | 1 |
963 | non-attached | 1 |
964 | steam-cooked | 1 |
965 | bicycled | 1 |
966 | muddled | 1 |
967 | immersion-chilled | 1 |
968 | unpoled | 1 |
969 | to-be-stopped | 1 |
970 | non-ordered | 1 |
971 | stored-filtered | 1 |
972 | nicotine-administered | 1 |
973 | precolored | 1 |
974 | ivus-measured | 1 |
975 | characteristic-based | 1 |
976 | tbc-exposed | 2 |
977 | dispersant-exposed | 1 |
978 | co-depressed | 1 |
979 | aminophylline-treated | 3 |
980 | hyper-methylated | 1 |
981 | minocycline-rifampin-impregnated | 1 |
982 | interleukin-2-activated | 1 |
983 | not-prescribed-when-unwarranted | 1 |
984 | exapted | 1 |
985 | unformatted | 1 |
986 | dual-mixed | 1 |
987 | stablilized | 1 |
988 | pregd | 1 |
989 | lithobid | 1 |
990 | avoid/non-avoid | 1 |
991 | qam-tid | 1 |
992 | mph+ld | 1 |
993 | =100-fold | 1 |
994 | otherworld | 1 |
995 | non-hood | 1 |
996 | 2rda-e | 1 |
997 | lighting/ae | 1 |
998 | light/ae | 1 |
999 | rate-place | 1 |
1000 | short-message-service | 1 |
1001 | overcompliance | 1 |
1002 | 1/clearance | 1 |
1003 | midsubstance | 1 |
1004 | ihc2+/fluorescence | 1 |
1005 | vindesine-etoposide | 1 |
1006 | tm-mode | 1 |
1007 | ntde | 1 |
1008 | flexknife | 1 |
1009 | pre/post-change | 1 |
1010 | spermatocele | 3 |
1011 | foradile | 1 |
1012 | pansystole | 1 |
1013 | aminotriazole | 1 |
1014 | dark-purple | 1 |
1015 | i.time | 1 |
1016 | lithane | 1 |
1017 | 2,3-dihydroxynaphthalene | 1 |
1018 | oxyethylene | 5 |
1019 | 1,1,1-trichloropropene | 1 |
1020 | exemestene | 1 |
1021 | 4-methylpyridine | 1 |
1022 | nevirapine+zidovudine/lamivudine | 1 |
1023 | methyldiphenylphosphine | 1 |
1024 | clorgiline | 1 |
1025 | mepyramine | 1 |
1026 | 6-chloro-3-deazaadenine | 1 |
1027 | butyroyl-arginine | 2 |
1028 | 3-hydroxycotinine/cotinine | 1 |
1029 | clothiapine | 1 |
1030 | amlopdipine | 1 |
1031 | hydroxydeoxyguanosine | 1 |
1032 | fluctine | 1 |
1033 | placebo+reboxetine | 1 |
1034 | low-tar/low-nicotine | 1 |
1035 | procarbazine/lomustine/vincristine | 1 |
1036 | maxaquine | 1 |
1037 | chlorprotixine | 1 |
1038 | 17-one | 1 |
1039 | gingilone | 1 |
1040 | pinacolone | 1 |
1041 | clonidine/naltrexone | 1 |
1042 | fluoropentyne | 1 |
1043 | top-rope | 2 |
1044 | protocolized-care | 1 |
1045 | kidney-failure | 1 |
1046 | intimidation/pressure | 1 |
1047 | cd+zn+se | 1 |
1048 | metastase | 1 |
1049 | fujianese | 1 |
1050 | venvanse | 1 |
1051 | cellulose/glucose | 1 |
1052 | i-dose | 1 |
1053 | ladose | 1 |
1054 | observe/investigate | 1 |
1055 | o-hydroxylate | 1 |
1056 | carrageenate | 1 |
1057 | phosphonacetyl-l-aspartate | 1 |
1058 | hydrolystate | 1 |
1059 | 27-minute | 1 |
1060 | cisplatin-cumulative | 1 |
1061 | k-sensitive | 1 |
1062 | 3-consecutive | 1 |
1063 | anticoagulant-naïve | 1 |
1064 | obese.we | 1 |
1065 | lomwe | 1 |
1066 | 'wheeze | 1 |
1067 | y321f | 1 |
1068 | locarbacef | 1 |
1069 | sf2/asf | 7 |
1070 | gus-hsf | 1 |
1071 | agotf | 2 |
1072 | /vf | 1 |
1073 | 212°f | 1 |
1074 | mir-146a*g | 1 |
1075 | arenes/g | 1 |
1076 | 600mcg | 1 |
1077 | 1,400-mg | 1 |
1078 | 1600mg | 1 |
1079 | 24.2mg | 1 |
1080 | jetamul-pleung-dang | 1 |
1081 | schinseng | 1 |
1082 | shinseng | 1 |
1083 | postbinding | 1 |
1084 | regional/teaching | 1 |
1085 | lip-licking | 1 |
1086 | iff.drinking | 1 |
1087 | multi-skilling | 1 |
1088 | pre-gaming | 1 |
1089 | non-swimming | 1 |
1090 | reflection/scattering | 1 |
1091 | flattering | 1 |
1092 | scooting | 1 |
1093 | two-serving | 1 |
1094 | deltafpg | 1 |
1095 | -dhpg | 4 |
1096 | tim-3tg→tim-3tg | 1 |
1097 | cd→g | 1 |
1098 | 148-μg | 3 |
1099 | =15/h | 2 |
1100 | ≥300mg/24h | 1 |
1101 | loofah | 1 |
1102 | ‘dash | 1 |
1103 | 3rd/4th | 1 |
1104 | =75th | 3 |
1105 | death-with | 1 |
1106 | cl-tai | 1 |
1107 | amnestic-mci | 2 |
1108 | dudhi | 1 |
1109 | box-ii | 1 |
1110 | =ii | 6 |
1111 | gr.iii | 1 |
1112 | =iii | 3 |
1113 | nstami | 1 |
1114 | demand/semi | 2 |
1115 | nsmri | 1 |
1116 | snap-back | 1 |
1117 | alcohol-interlock | 1 |
1118 | =6-week | 1 |
1119 | peruik | 1 |
1120 | 3x/wk | 2 |
1121 | 60mg/l | 1 |
1122 | 0.39mmol/l | 1 |
1123 | 3.5-μmol/l | 1 |
1124 | non-verterbal | 1 |
1125 | bolheal | 1 |
1126 | 6-meal | 1 |
1127 | reliseal | 1 |
1128 | crosseal | 1 |
1129 | prejugal | 1 |
1130 | sb0thal | 1 |
1131 | sβ0thal | 2 |
1132 | trofibial | 1 |
1133 | luminal/proximal | 1 |
1134 | diflusinal | 1 |
1135 | unproportional | 1 |
1136 | inter-clonal | 1 |
1137 | lagoonal | 1 |
1138 | equal | 5,791 |
1139 | nocl | 1 |
1140 | =0.1g/dl | 1 |
1141 | 500-1000mg/dl | 1 |
1142 | 300-500mg/dl | 1 |
1143 | vitagel | 1 |
1144 | lipidil | 1 |
1145 | -imidapril | 1 |
1146 | atenolol/hydrochlorothiazide/trandolapril | 1 |
1147 | nifedipine-atenolol | 1 |
1148 | 4-phenyl-2-butanol | 1 |
1149 | n-hexanol | 1 |
1150 | ginsenol | 1 |
1151 | =400000/microl | 1 |
1152 | =500/microl | 2 |
1153 | tiotropium/salmeterol | 1 |
1154 | mivazerol | 3 |
1155 | cyclic/control | 1 |
1156 | lynestrol | 1 |
1157 | 7-hexanoyltaxol | 1 |
1158 | β-flupenthixol | 1 |
1159 | triazol | 1 |
1160 | quinolin-6-yl | 1 |
1161 | o-cmeth-yl | 1 |
1162 | γ-methyl | 1 |
1163 | -2-butoxymethyl | 1 |
1164 | -arylalkyl | 1 |
1165 | 4-methyl-thiazolyl | 1 |
1166 | 4,5-dehydrogeranyl | 1 |
1167 | 2-deoxy-glucopyranosyl | 1 |
1168 | g1/g2-m | 1 |
1169 | gel/cream | 3 |
1170 | eusaprim | 1 |
1171 | theotrim | 1 |
1172 | ppd4-5mm | 1 |
1173 | restroom | 1 |
1174 | 169-erbium | 1 |
1175 | quilonum | 1 |
1176 | orthonovum | 1 |
1177 | placebo-edoxaban | 1 |
1178 | =median | 1 |
1179 | fockian | 1 |
1180 | inogatran | 1 |
1181 | 2,4-diacyl-2-hydroxylmethyl-2,3-dihydrofuran | 1 |
1182 | luteoliflavan | 1 |
1183 | tang-min-ling-wan | 1 |
1184 | et/dn | 1 |
1185 | 40en | 1 |
1186 | 25en | 1 |
1187 | adofen | 1 |
1188 | dexibruprofen | 1 |
1189 | bcr/antigen | 1 |
1190 | polyantigen | 1 |
1191 | lorien | 1 |
1192 | females/pen | 1 |
1193 | fluoxeren | 1 |
1194 | enthalpy-entropy-driven | 1 |
1195 | zalain | 1 |
1196 | acemetacin | 1 |
1197 | micamycin | 1 |
1198 | cow-milk-protein | 1 |
1199 | panaxagin | 1 |
1200 | nuelin | 1 |
1201 | moxicillin | 1 |
1202 | elixophyllin | 2 |
1203 | iodoinsulin | 1 |
1204 | =2-min | 2 |
1205 | insulin±metformin | 1 |
1206 | lactoalbumin | 1 |
1207 | -doxepin | 1 |
1208 | lactadherin | 3 |
1209 | spiroplatin | 1 |
1210 | beta-keratin | 1 |
1211 | beta-hydroxylovastatin | 2 |
1212 | fluctin | 1 |
1213 | syringetin | 1 |
1214 | flupirtin | 1 |
1215 | tselutin | 1 |
1216 | zadaxin | 1 |
1217 | vasodepression | 1 |
1218 | desensiti*ation | 1 |
1219 | non-communication | 1 |
1220 | aggregation-degradation | 1 |
1221 | -insufflation | 1 |
1222 | trihydroxylation | 2 |
1223 | damnation | 1 |
1224 | over-elaboration | 1 |
1225 | re-registration | 1 |
1226 | deculturation | 1 |
1227 | hypersensation | 1 |
1228 | non-citation | 1 |
1229 | rs-infection | 1 |
1230 | tsn-injection | 1 |
1231 | pain-induction/anger-induction | 1 |
1232 | moxibution | 2 |
1233 | bedoon | 1 |
1234 | metylperon | 1 |
1235 | saline/ondansetron | 1 |
1236 | reneuron | 1 |
1237 | 210mg/min/person | 1 |
1238 | taper-down | 1 |
1239 | etiology-unknown | 1 |
1240 | prozyn | 1 |
1241 | kugancao | 1 |
1242 | h2/n1co | 1 |
1243 | chemoradio | 1 |
1244 | 'musa-pelo | 1 |
1245 | o-mo | 1 |
1246 | ε-amino | 1 |
1247 | chuchuaso | 1 |
1248 | otherwise.to | 1 |
1249 | asusto | 2 |
1250 | s-trans-ch2chċo | 2 |
1251 | yào | 4 |
1252 | =ff=cap | 2 |
1253 | erocap | 1 |
1254 | α-d-glcp | 1 |
1255 | veip | 1 |
1256 | mbpp | 1 |
1257 | θ-zrp | 1 |
1258 | stepping-up | 1 |
1259 | 45/group | 1 |
1260 | nevirapine-nvp | 1 |
1261 | ssz+hcq | 6 |
1262 | gpqgiagq | 1 |
1263 | 'headgear | 1 |
1264 | ssris-appear | 1 |
1265 | =3/year | 1 |
1266 | cfl/glabellar | 1 |
1267 | perpendic-ular | 2 |
1268 | peri-bronchovascular | 1 |
1269 | cross-columnar | 1 |
1270 | anh/ibr/pbr | 2 |
1271 | non-spacer | 1 |
1272 | pneumotachograph/flow-trigger | 1 |
1273 | flutter/pacemaker | 1 |
1274 | metreurynter | 1 |
1275 | pseudo-cluster | 1 |
1276 | ldhi—lower | 1 |
1277 | torasemide-ir | 1 |
1278 | fed-pair | 1 |
1279 | complete/repair | 1 |
1280 | both.for | 1 |
1281 | single-inhibitor | 1 |
1282 | bg/gtr | 1 |
1283 | sanzur | 1 |
1284 | cibalith-s | 1 |
1285 | fibringluraas | 1 |
1286 | chocholtecs | 1 |
1287 | uroseptics | 1 |
1288 | oculomotor-leads | 1 |
1289 | 5β-dihydrosteroids | 1 |
1290 | ∆smds | 1 |
1291 | head-braces | 3 |
1292 | cpap-devices | 1 |
1293 | 'preferences | 2 |
1294 | saccarides | 1 |
1295 | monthes | 1 |
1296 | n-vacancies | 1 |
1297 | other-therapies | 1 |
1298 | micro-injuries | 1 |
1299 | non-linearities | 1 |
1300 | 3-hydroxy-3-hydroxymethyloxindoles | 1 |
1301 | trychomes | 1 |
1302 | 3-glutathionyl-1,4-dihydroxy-5,8-dimethoxynaphthalenes | 1 |
1303 | propanolamines | 1 |
1304 | 3,4-dihydroquinolin-2-ones | 1 |
1305 | bathhouses | 1 |
1306 | np-a50-fs | 1 |
1307 | history/findings | 1 |
1308 | awnings | 1 |
1309 | herrings | 1 |
1310 | diet+drugs | 1 |
1311 | la-hs | 1 |
1312 | delphis | 2 |
1313 | al-mis | 1 |
1314 | stop*.alois | 1 |
1315 | csld/bronchiectasis | 1 |
1316 | rhabdmyolysis | 2 |
1317 | endomyoparametritis | 2 |
1318 | la-ls | 1 |
1319 | agri-chemicals | 1 |
1320 | γ-ketoenals | 1 |
1321 | basdai-levels | 1 |
1322 | dihydroxycholecalciferols | 1 |
1323 | progams | 1 |
1324 | discograms | 1 |
1325 | microerosions | 1 |
1326 | self-mutilations | 1 |
1327 | combinations/augmentations | 1 |
1328 | nnips | 1 |
1329 | traffickers | 1 |
1330 | ca-blockers | 1 |
1331 | n-mers | 1 |
1332 | stammers | 1 |
1333 | lighters | 3 |
1334 | muco-regulators | 1 |
1335 | her2-inhibitors | 1 |
1336 | ×qrs | 1 |
1337 | state-effects | 1 |
1338 | ntagonists | 1 |
1339 | glycoprotein-receptoriib/iiia-antagonists | 1 |
1340 | bifocus | 1 |
1341 | tarandus | 1 |
1342 | otogeneous | 1 |
1343 | 'days | 3 |
1344 | =7days | 1 |
1345 | prf/fat | 1 |
1346 | -fluoride-pet/ct | 1 |
1347 | relational/indirect | 1 |
1348 | 12/diet | 1 |
1349 | pinset | 1 |
1350 | nissen/gt | 1 |
1351 | bucking/caught | 1 |
1352 | fruitafit | 1 |
1353 | eight-digit | 1 |
1354 | zerit | 1 |
1355 | sirna-akt | 1 |
1356 | interferon-intolerant | 1 |
1357 | tnf-blocker-resistant | 2 |
1358 | tinaquant | 1 |
1359 | radiologist/resident | 1 |
1360 | simvastatin-equivalent | 1 |
1361 | near-equivalent | 1 |
1362 | partner-with-encouragement | 1 |
1363 | non-complement | 1 |
1364 | high-treatment | 2 |
1365 | dual-treatment | 2 |
1366 | placebo.treatment | 2 |
1367 | alpist | 1 |
1368 | tim-3tg→wt | 1 |
1369 | flubu | 1 |
1370 | clou | 1 |
1371 | light/tu | 1 |
1372 | ipsv/cedv | 2 |
1373 | placebo+opv | 1 |
1374 | mid-to-low | 1 |
1375 | p.w147x | 1 |
1376 | sem/wdx | 1 |
1377 | fontex | 1 |
1378 | docutrix | 1 |
1379 | =3g/day | 1 |
1380 | -32mg/day | 1 |
1381 | -363mg/day | 1 |
1382 | =2h/day | 1 |
1383 | sterol/day | 1 |
1384 | dermatology-oncology | 1 |
1385 | diazotrophy | 1 |
1386 | biotically | 1 |
1387 | dysynergistically | 1 |
1388 | subfascially/subcutaneously | 1 |
1389 | light-therapy | 1 |
1390 | brathytherapy | 1 |
1391 | low-enthalpy | 1 |
1392 | cervicoscopy | 1 |
1393 | laryngofibroscopy | 1 |
1394 | delayed-recovery | 1 |
1395 | tanse-tansy | 1 |
1396 | toxicogenicity | 1 |
1397 | quenchability | 1 |
1398 | specularity | 1 |
1399 | ast-activity | 1 |
1400 | snowy | 1 |
1401 | |q| | 2 |
1402 | ethibond™ | 2 |
1403 | diff-quick™ | 1 |
1404 | amulet™ | 1 |
1405 | dysport™ | 2 |
1406 | luminex™ | 1 |
1407 | not… | 1 |
1408 | abzé | 1 |
1409 | 'teflon'® | 1 |
1410 | tetavax® | 1 |
1411 | pandemrix® | 1 |
1412 | =0° | 1 |
1413 | sf-il-1β | 2 |
1414 | ll5β | 2 |
1415 | pifithrin-µ | 1 |
1416 | ¿slc12a3¿ | 1 |